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Summary
Ribosome inactivating proteins (RIPs) are currently classified as rRNA N-glycosidases, but
also have polynucleotide: adenosine glycosidase activity. RIPs are believed to have anti-viral
and anti-fungal properties, but the exact mechanism of these proteins still need to be
elucidated.The mechanism of resistance however, appears to be independent of the pathogen.
For resistance the RIP terminates virus infected plant cells and stops the reproduction and
spread of the virus. Transgenic plants containing RIPs should thus be resistant to a wide
range of viruses. The ultimate goal of the larger project of which this forms part is the
development of virus resistant plants. To monitor the expression of a RIP in a transgenic
plant a detection method had to be developed. Antibody detection of the RIP was decided
upon as the most cost effective method. The RIP, Dianthin 30 from Dianthus caryophyllus
(carnation),was used and expressed in bacterial and insect expression systems. The bacterial
expression experiments were done using the pET expression system in BL21(DE3)pLysS
cells. The expression in this system yielded recombinant protein at a very low concentration.
Expression experiments were also performed in insect tissue culture with the baculovirus
vector BAC-TO-BAC™.With this system the expression was also too low to be used for the
production of antibodies. A Dianthin 30 specific peptide was then designed and then
produced by Bio-Synthesis. This peptide was then used to raise antibodies to detect Dianthin
30. These antibodies were tested on Dianthus caryophyllus proteins. To establish if this
detection method was effective to monitor the expression in plants, tobacco plants were
transformed with Agrobacterium tumefaciens containing Dianthin 30 in the pART27 plant
expression vector. The putative transformed plants were analysed with peR and Southern
blots.
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Opsomming
Tans word Ribosomale-inaktiverende proteïene (RIPs) geklassifiseer as rRNA N-glikosidase
wat ook polinukleotied: adenosien glikosidase aktiwiteit bevat. Daar word geglo dat RIPs
anti-virale en anti-fungus eienskappe bevat, maar die meganisme van beskerming word nog
nie ten volle verstaan nie. Dit is wel bewys dat die meganisme van weerstand onafhanklik is
van die patogeen. Virus geinfekteerde plantselle word deur die RIP gedood om die
voortplanting en verspreiding te bekamp en sodoende word weerstand bewerkstellig.
Transgeniese plante wat dan 'n RIP bevat sal dus weerstandbiedend wees teen 'n wye
spektrum virusse. Die hoofdoel van die breër projek, waarvan die projek deel uitmaak: is die
ontwikkeling van virusbestande plante. Om die uitdrukking van die RIP in die transgeniese
plante te kontroleer, moes 'n deteksie metode ontwikkel word. Die mees koste effektiewe
deteksie metode is met teenliggame. Die RIP, Dianthin 30 from Dianthus caryophyllus
(angelier) was gebruik vir uitdrukking in bakteriele- en insekweefselkultuur. Die bakteriele
uitdrukkingseksperimente was gedoen met die pET uitdrukkings sisteem III
BL21(DE3)pLysS selle. Die uitdrukking in die sisteem het slegs rekombinante proteïene
gelewer in uiters lae konsentrasies. Uitdrukkingseksperimente was ook gedoen in
insekweefselkultuur met die baculovirus vektor BAC-To- BACTM. Met die sisteem was die
uitdrukking ook veels te laag om bruikbaar te wees vir die produksie van teenliggame. Daar
is toe 'n peptied ontwerp wat Dianthin 30 kan verteenwoordig vir die produksie van
teenliggame. Die teenliggame is getoets teen Dianthus caryophyllus proteïene. Om vas te stel
of die deteksiemetode wel die uitdrukking van Dianthin 30 sal kan monitor, is tabak ook
getransformeer met Dianthin 30. Die transformasies is gedoen met die hulp van
Agrobacterium tumefaciens en die pART27 plant uitdrukkings vektor. Die plante is getoets
met die polimerase ketting reaksie en Southern klad tegnieke.
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"As being is to becoming, so is pure intellect to opinion. And as
intellect is to opinion, so is science to belief, and understanding to the
perception of shadows."
Plato, Republic BookVII
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1Chapter 1: Introduction
1.1. Background to the study
1.1.1. Why this study?
Vilis vinifera belongs to the family Vitaceae and is economically the most important
grapevine. Viticulture in South Africa started with the arrival of Simon van der Stel as
governor to the Cape in 1679 and since then South Africa has grown to the eighth largest
producer of wine in the world [1]. According to a study commissioned by the SA Wine
Industry Information and Systems (SAWIS) the South African wine industry employs more
than 348 500 people with wine tourism adding an additional 48 350 people. In the Western
Cape alone the industry generates over R18 billion per annum [1].
Grapevine is host to many pathogens of which viruses are currently the most devastating in
South Africa. Unlike other pathogens like bacteria or fungi there is no "cure" for infected
plants. All efforts are presently being put into preventing the disease in vineyards by spraying
for vectors and by planting uninfected vines once the infected vines are removed. Infected
vines will usually not die from the disease but the yield and quality of the fruit will be
affected with delayed and uneven ripening and low sugar content [2].
The virus problem in South Africa is taking on epidemic proportions affecting harvests in all
the mayor regions. In 2001, Winetech identified viruses and more specific GLRaV-3 as the
most devastating pathogen on South African vines.
1.1.2. This thesis
At the current rate, conventional agricultural methods of introducing resistance to viral
pathogens in grapevine will soon not be able to keep up with the growing problem. This is the
main reason why research into transgenic crops and in our case grapevine is a very relevant
and active field. Currently, there is a limited acceptance of transgenic crops due to the
perceived hazards, but that perception should change in the future. It is thus necessary to
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2research the fundamental principals now, so that crops and products can be ready or in an
advanced state of testing by the time transgenic crops do get accepted [3].
To combat the onslaught of the viral pathogens on our grapevine, Winetech launched a large
project in collaboration with the University of Stellenbosch Genetics Department and Institute
for Wine Biotechnology. In this project, the aim was to introduce virus resistance into
grapevine using various approaches. This thesis is the third on this project, the first two are
briefly described in 1.1.3 and 1.1.4.
1.1.3. The construction of plant expression vectors for the introduction of leafroll
resistance in grapevine. CD. van Straten
This project was performed by C.D. van Straten as part of an MSc study. The aim was to
engineer virus resistance, specifically to GLRaV-3, into grapevine. To achieve this resistance,
a pathogen-derived method of coat protein-mediated resistance was used. Plant expression
vectors were constructed to express the sense and antisense of the coat protein gene of
Grapevine leafroll associated virus III and tested it in tobacco. She was unable to produce
transgenic tobacco or grapevine plants [4].
1.1.4. Investigating the introduction of a broad-spectrum antiviral mechanism into
grapevine. K.L. Wilsen
This project was done by K.L. Wilsen as part of an MSc study. The aim of this project was to
investigate the possibility of using a heterologous resistance gene to engineer resistance into
tobacco and grapevine. The first steps were to isolate different ribosome inactivating protein
(RIP) genes and clone them into expression vectors. She was unable to isolate a RIP gene
from the grapevine genome but was able to do so from other plants that were known to
contain these proteins. She was unable to express these genes in bacteria [5].
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31.2. Current study
1.2.1. Current project outline
In this study, the use a heterologous resistance gene to engineer virus resistance into tobacco
as a model for grapevine was investigated. The project, involved the introduction of a
ribosome inactivating protein (RIP) into tobacco as well as the development of a detection
method to monitor the expression of the RIP in tobacco. For this project the RIP, Dianthin 30
from Dianthus caryophyllus was used.
1.2.2. Aims
The main focus of this thesis was the expression of Dianthin 30 for the development of a
detection method that would monitor the expression of the protein in transgenic plants. An
immunological detection method was chosen, and for this purpose rDianthin 30 had to be
expressed. Expression was initially targeted only in bacteria, but insect cells were later also
included. The recombinant protein then had to be purified for the production of antibodies in
rabbits. The antibodies then had to be evaluated on carnation and transgenic plants. The
transgenic plants were generated by Agrobacterium tumefaciens mediated transformation and
a suitable plant expression vector.
1.3. Chapter layout
1.3.1. Chapter 2
In this chapter, ribosome inactivating proteins (RIPs) are reviewed, focussing on their
properties and their current applications in agriculture.
1.3.2. Chapter 3
Chapter 3 describes the expression of Dianthin 30 in bacterial expression systems. The system
used was the pET expression system, developed by Novagen.
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41.3.3. Chapter 4
This chapter describes the expression of Dianthin 30 in insect tissue culture using a
baculovirus vector for the expression. For this the BAC-TO-BAC™ system from Monsanto
was used.
1.3.4. Chapter 5
In Chapter 5, the design of a unique peptide to represent Dianthin 30 as an antigen is
described as well as the analyses of the serum from the inoculated rabbits.
1.3.5. Chapter 6
Agrobacterium mediated transformation of tobacco leaf material with the plant expression
vector pART27 containing the Dianthin 30 gene is described in Chapter 6.
1.3.6. Chapter 7
Chapter 7, contains the concluding remarks on the thesis and the research done.
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5Chapter 2: Review of Ribosome inactivating proteins (RIPs)
2.1. Introduction
During the past 15 years, scientists have been able to increase our understanding into the
molecular mechanisms of protein toxins that inhibit protein synthesis. These toxins inhibit
eukaryotic cellular protein synthesis by either NAD+-dependent adenosine diphosphate
ribosylation of elongation factor 2 (EF-2) or by functioning as an N-glycosidase to remove
adenine 4324 (A4324) from 28S rRNA. In both cases the target is permanently altered and
unable to continue with protein synthesis, and if enough EF-2s or ribosomes are damaged
the cell will die [6].
2.1.1. History
The toxic properties of RIPs are not a new discovery. In ancient Chinese medicine, the
root tuber of Trichosanthes kirilowii Maxim. was an ingredient in Tianhuafen that was
used to induce abortions [7, 8, 9]. Modem science later confirmed the activity of this
potent medicine and discovered that the active ingredient is the RIP, Trichosanthin [9, 10].
Western scientists have known about toxins such as ricin (from the seeds of Ricinus
communis, the castor bean) and abrin (from the seeds of Abrus precatotius, the jequirity
bean) for a long time, before it was discovered that these toxins were RIPs. In fact, in
1887, Dixon suspected that the toxicity of the castor beans could be attributed to a protein,
and in 1888, Stillmark purified the protein and called it ricin. Three years later Hellin
purified another RIP, abrin [reviewed by 11 and 12]. The toxicity of these proteins was
then attributed to their ability to agglutinate erythrocytes.
2.1.2. RIPs as virus transmission inhibitors
Gendron et al. have observed the effect of RIPs on mechanical transmission of plant
viruses in 1954 [13]. They concluded that the sap of Phytolacca decandra, sugar beet and
carnation contains substances that can act as virus inhibitors. From their studies, they
concluded that there was some evidence that the action of inhibition was on the plant
rather than the virus [13]. Thomlinson et al. made some significant discoveries when they
observed that the "plant virus inhibitor" from Phytolacca americana (American
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6pokeweed) was not only able to inhibit virus infection in plants but was also able to inhibit
the transmission of animal viruses (influenza) in mammalian tissue culture [14].
Owens et al. (1973) found that the virus inhibiting extracts of pokeweed was able to
disrupt protein synthesis in cell free protein synthesis systems and concluded that the
mechanism of inhibition must be on the ribosomes [15]. Montanaro et al. came to the
same conclusion in 1973 but narrowed the mechanism of inhibition down to the
interaction between the ribosome and EF-2 [16].
2.1.3. Renewed interest in RIPs and subsequent classification
Studies on these toxins (RIPs) came under the spotlight in 1970 when Lin et al. reported
that these toxins were more toxic to tumor cells (Ehrlich ascites) inoculated
intraperitoneally to mice than normal cells [17].
This discovery was followed by a revival in the research of these toxins and led to the
definition of the two-chain structure for ricin and abrin (later referred to as type-2 RIPs).
Obrig et al. described the first type-1 RIP in 1973 [18]. The RIP they found was isolated
from leaf extracts of Phytolacca americana and called it pokeweed antiviral protein
(PAP). Since then many other type-1 RIPs have been found (see Table 2.1) from a wide
range of plants of different plant families. Another RIP, Modeccin (from Adenia
(Modecca) digitata), was found by Stirpe et al. in 1978 and classified as a type-2 RIP.
Since then very few type-2 RIPs have been discovered [19](see Table 2.2).
Itwas proposed in 1983 by Barbieri and Stirpe that this group of proteins be referred to as
Ribosome-Inactivating Proteins (RIPs) [20]. The general consensus at that time was that
RIPs could be defined as proteins " ... that inactivate eukaryotic ribosomes in a catalytic
(enzymatic) manner, rendering the 60S ribosomal subunit incapable of binding the
elongation factor 2, and thus arresting protein synthesis." [21].
They also proposed that RIPs be divided into two major categories: type-1 RIPs which
have a single chain of protein (similar to the A-chain of type-2), and the type-2 RIPs
which have two chains of protein, the Active- and Binding-chain (see Figure 2.1). Studies
now suggest that type-2 RIPs might have evolved from type-1 RIPs [20,22].
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7TABLE 2.1
Purified type-l ribosome inactivating proteins
Family, genus and species Plant tissue Name Yield (mg/100g)
Asparagaceae Asparagus officinalis Seeds asprin I 5.4
asprin 2 4.9
Caryophyllaceae Agrostemma githago Seeds Agrostin 2 8.4
Agrostin 5 34.2
Agrostin 6 18.4
Saponaria officinalis Leaves Saporin - LI 35
Leaves Saporin - L2 13
Roots Saporin - Rl 20
Roots Saporin - R2 5
Roots Saporin - R3 9
Seeds Saporin - S5 63
Seeds Saporin - S6 268-414
Seeds Saporin - S8 15
Seeds Saporin - S9 24
Cucurbitaceae Cucumis melo Seeds Melonin
Momordica charantia Seeds Momordin I 150-180
Momordin II
Trichosanthes kirilowii Roots Trichosanthin 140
Roots a - trichosanthin
Roots TAP29 2
Seeds Trichokirin 5.7
Eyphorbiaceae Gelonium multiflorum Seeds Gelonin 250-300
Hura crepitans Latex Hura crepitans RIP 146
Nyctaginaceae Mirabilis jalapa tissue culture MAP 3
Roots MAP 90
Phytolaccaceae Phytolacca americana Leaves PAP 9.2
PAP II 3.6
Seeds PAP-S 100-180
tissue culture PAP-C 17.5
Roots PAP-R 7
Phytolacca dodecandra Leaves Dodecandrin 3.4
tissue culture Dodecandrin - C I
Poaceae Hordeum vulgare Seeds Barley RIP 139
Triticum aestivum Germ Tritin 3
Seeds Tritin 32
Zea mays Seeds Maize RIP 12.1-20
Table adapted from Barbieri et al. (1993) [Il].
TABLE2.2
Purified type-2 ribosome inactivating proteins
Family, genus and species Plant tissue Name Yield (mg/iOOg)
Euphorbiaceae Ricinus communis Seeds ricin D
ricin E
Ricinus agglutinin
abrin a
abrin c
Modeccin
Modeccin6B
Volkensin
ebulin I
P. californ. Lectin
Viscumin
120
Fabaceae Abrus precatorius Seeds
Passifloraceae Adenia digitata Roots
Adenia volkensii Roots
Sambucaseae Sambucus ebulus Leaves
Viscaceae Phoradendron californicum Leaves
Viscum album Leaves
75
20-180
7
0.2
3.2
7
Table adapted from Barbieri et al. (1993) [lI].
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Figure 2.1. Schematic representation of the structure of type-1 and type-2
ribosome-inactivating proteins. The A-chain is a polypeptide with N-glycosidase
activity. The B-chain is a polypeptide with lectin activity [11].
From Figure 2.'1. the differences between the two types of RIPs, a type-1 and a type-2 can
clearly be seen. Ricin and abrin are both type-2 RIPs. The discovery of new RIPs that did
not fit this mold lead to the classification of a type-3 RIP [23]. At first the "type-I" RIPs
that underwent proteolytic modification were also part of this group but re-evaluation of
this classification suggested that type-1 RIPs be re-grouped so that type-1 RIPs now
consist of one-chain and two-chain RIPs [12].
This restructuring now allows for all the type-1 RIPs that undergoes proteolytic
modification to be named two-chain type-1 RIPs. The term type-3 RIP is reserved for the
truly different RIPs like, JIP60 from barley, (Hordeum vulgare) and other not yet
discovered proteins with properties similar to JIP60. JIP60 is a 60 kDa protein that
consists of two linked domains: an N-terminal domain with the properties of a type-1 RIP
and aC-terminal of unknown function [23]. For this suggested re-classification see Figure
2.2.
Two-chain type-l RIP -- _ N-glycosidase Domain_ Lectin DomainD Unknown Domain
One-chain type-l RIP
Type-l RIP
Type-2RIP
Type-3RIP
Figure 2.2. Schematic representation of the molecular structure of different types
of RIPs as suggested by Peumans et a/. [12].
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9After the structure of RIPs was elucidated, the enzymatic activity had to be determined.
Endo et al. described the RNA N-glycosidase activity of ricin A-chain on ribosomes and
rRNA [24, 25, 26]. Ribosome inactivating proteins are presently classified as rRNA N-
glycosidases rsc 3.2.2.22].
2.2. General
2.2.1. Distribution
The distribution of RIPs in the plant kingdom has not been studied intensively, mainly
because scientists were searching for new RIPs in related plants, rather than in new
classes. Most RIPs discovered up to 1993, were from the Angiospermae class and from
both monocotyledonae and dicotyledonae. No RIP has yet been isolated from the
Gymnospermae [11].
The similarities in activity between shiga toxin (Stx), produced by some E. coli strains,
and RIPs in general lead some scientists to group these toxins together [27, 28]. Similarly,
N-terminal sequence homology of the proteins, Flammulin (from the winter mushroom,
Flammulina velutipes) and Lyophyllin (from Lyophyllum shimeji) to RIPs make it possible
to categorize these proteins with the plant RIPs [29, 30]. Other fungus toxins such as u-
sarein (from Aspergillus giganteus) are sometimes also grouped with RIPs [31]. The latest
twist to this tale is the discovery of RIP-like proteins in mammalian tissue culture cells
that suggests that RIPs might even be more widely spread than originally thought [32].
2.2.2. Structure
The type-1 RIPs are very similar to each other in structure. All consist of only a single
polypeptide that has the same properties as the A-chain of the type-2 RIPs. The structural
similarities between type-1 RIPs and the A-chain of the type-2 RIPs are illustrated in
Figure 2.3.
."'" ~.IJ S' •
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Figure 2.3. Superimposition of the 3-D models ofirisRIP.A3 (thick line) with the
A-chains of ricin and abrin as well as the type-1 RIPs u-momorcharin and
trichosanthin (thin lines) [33].
The type-2 RIPs are composed of an A-chain that is bound to a B-chain via a disulphide
bond and other non-covalent bonds (see Figure 2.1). The type-2 RIPs can consist of two or
four polypeptide chains linked together, and have an estimated molecular mass of 60 000
or 120 000 Da. Type-2 RIPs such as ricin, abrin and modeccin are heterodimers whilst
viscumin is a tetramer consisting of two heterodimers held together by non-covalent bonds
[34,35].
The three-dimensional structure of ricin was examined after crystallization at 2.8 A and
2.5 A [36]. This revealed that the A-chain was globular with a well-defined cleft (see
Figure 2.4). This cleft was investigated and it was found that it held the enzymatic site.
The B-chain was examined and was shown to be a gene duplication product. It was also
shown that the B-chain consisted of two domains, and that it has a binding site for lactose
in a shallow cleft. With X-ray diffraction it was confirmed that the A-and B-chain are held
together by a disulphide bridge and other non-covalent bonds (hydrophobic interactions).
This can be seen in the ribbon structure in Figure 2.5 .
..
Figure 2.4. The putative active site cleft of the ricin A-chain [37].
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Figure 2.5. Ribbon representation of the ricin backbone. The A-chain is in the
upper right and the B-chain is the lower left [37].
2.2.3. Physicochemical properties
The sizes of RIPs have been determined usmg SDS-P AGE and were found to be
approximately 30 000 Da for the A-chain and the B-chain within a 10% error (see Table
2.3). The pI of the A-chain cannot be measured but is basic (>9.5) [11]. The pI of the type-
2 RIPs has been determined and varies from 4.6-8.8. As can be seen in Table 2.3, most of
the RIPs are glycoproteins that do not seem to playa role in their enzymatic activity but
rather with their way of internalization. The genes of many RIPs have been sequenced (see
Table 2.4), and very little nucleic sequence homology between the different RIPs was
found. However, with amino acid sequence alignment it was observed that the N-terminal
and core sequences were more conserved than the C-terminal, which might then explain
why some activities are conserved throughout the range of RIPs and other activities are
confined to certain groups [38].
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TABLE 2.3
Physico-chemical characteristics
RIP Molecular Neutral sugar Extinction
Mass (Da) Content (%) Coefficient at
280 nm(M)
TYPE-l RIPs
Agrostin 2 30600 6.68
Agrostin 5 29500 6.87
Agrostin 6 29600 7.17
Asprin 1 30500 Traces 30500
Asprin 2 29800 Traces 29800
Barley RIP 29976 27600
Dodecandrin 29000 0
Dodecandrin - C 31-32000 4.46
Gelonin 30000 21000
Hura crepitans RIP 27500 0.94 25200
Maize RIP 25000 0 26500
MAP 27833 0 24000
Momordinl 29092 1.74
Momordin II 30000 1.3
PAP 29000 0 24000
PAP-C 29000 Traces
PAP-R 29800 0 23800
PAP-S 29167 0 22500
PAP II 30000 0 26700
Saporin- LI 31600 29400
Saporin - L2 31600 26400
Saporin -Rl 30200 23200
Saporin-R3 30900 24700
Saporin- S5 29500 23800
Saporin - S6 29500 0
Saporin- S8 29500
Saporin - S9 29500 0
Trichokirin 27000 1.27 23330
Trichosanthin 24-29000 0
a - trichosanthin 27215
Tritin 30000
TYPE-2 RIPs
Abrin a 60100 5.5 70700
A chain 31000 Present
B chain 35500 Present
Abrin c 63800 7.4 82500
A chain 30000 0 23600
B chain 36000 7.4 63700
Ebulin 1 56000
A chain 26000
B chain 30000
Modeccin 60000 2.7
A chain 27800
B chain 31000
P. californ. Lectin 69000 14.1
A chain 31000
B chain 38000
RicinD 63-66000 5.5-6.2 77900
A chain 30000 4.5 23000
B chain 33000 6 50700
Ricin E 63000 Present
Ricinus agglutinin 120000 4.5 140400
A chain 31000
B chain 34000
Table adapted from Barbieri et al. (1993)[11).
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TABLE2.4
RIPs of which the sequence is known
RIP Genome eDNA Protein
Abrin •
Abrin-a •
Abrin c •
b 32/ maize RIP • •
Barley RIP • ...
Dianthin 30 •
Luffma • •
Luffin b • •
MAP • ... •
Momordica balsam ina RIP •
Momordinl •
PAP-S •
PAP • •
RicinD • • •
Rinus agglutinin ...
Saporin-S6 • • •
Trichosanthin ... ... ...
-Trichosanthin ...
Table adapted from Barbieri et al. (1993) [11].
2.2.4. Biosynthesis
To determine where and how RIPs are synthesized is quite difficult, because RIPs have
been found in all plant tissues, and at levels of expression that vary quite considerably.
Because of their enzymatic activities, RIPs must be synthesized in such a way that they are
not harmful to the cell. There are three possible ways in which the plants handle this
problem: i) the ribosomes of the cell are resistant to the RIP that is produced by the same
cell, ii) the RIP is first synthesized in a inactive pro-form, iii) the synthesis of a
preproform with an N-terminal signal sequence that directs the nascent peptide chain to
the lumen of the reticulum before it can be folded into its active form (see Figure 2.6).
Plants producing ricin seem to make use of the third pathway. The active ricin is then
stored in single membrane organelles in the endosperm of seeds [38]. In the case of
pokeweed, Ready et al. used electron microscopy and RIP specific antibodies to show that
the RIP PAP was produced and secreted over the cell membrane into the cell wall matrix
and was thus trapped in the intercellular matrix [38, 39].
It was observed with Beetins 27 and 29, from Beta vulgaris (sugar beet), that expression is
only induced when this plant has a virus infection, and in this case it is proposed that the
RIP has a cell death role and does not have to be compartmentalized [40].
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Figure 2.6. Synthesis of a protein and its translocation via the endoplasmic
reticulum [41].
2.3. Biological Activity
2.3.1. Enzymatic activity
2.3.1.1. rRNA-N glycosidase activity
Endo et al. (1987 (a),(b) and 1988) demonstrated that the functional damage by RIPs on
ribosomes is due to a modification of the rRNA of the ribosome. N-glycosidase activity of
both type-l RIPs and the A-chain oftype-2 RIPs were observed to cleave the N-glycosidic
bond of A4324 (see Figure 2.7) of 28S mammalian rRNA. It was also discovered that the
adenine residue that is cleaved is in a loop and stem sequence in rRNA that contain a
GAGA sequence. This sequence is the recognition site for EF-2, indicating that the RIPs
target a specific structure [11, 24, 34]. Some of these loop structures are shown in Figure
2.8.
Figure 2.7. Glycosidic links (marked in red) are between the nitrogen-base and
sugar to form nucleoside. This is where the RIP depurinates the rRNA [41].
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Figure 2.8. Structure of rRNA substrates for N-glycosidase activity of RIPs. (e) E.
coli., (h) Homo sapiens, (m) mouse, (0) Oryza sativa, (r) rat, (s) S. cerevisiae, (x)
X laevis [11, 37].
2.3.1.2. Site of action
The RNA N-glycosidase activity of RIPs that depurinate rRNA, is thus damaging the
ribosome and ultimately stopping protein synthesis [20, 24, 33, 34, 42-44]. Protein
synthesis cannot take place on ribosomes that have been damaged by RIPs. During
translation the function of the EF-2 is to translocate the uncharged tRNA when
hydrolysing the bound GTP [41]. The inability ofEF-2 to bind to the ribosome will halt
protein synthesis and because the damage is irreversible, the ribosome will be inactive and
unable to continue with protein synthesis.
The site of cleavage is highly specific and is adjacent to the site of cleavage by a group of
specific RNAases from fungi [34, 45]. c-Sarcin from the mould Aspergillus giganteus is
one of these RNAases that cleave the phosphodiester bond in rat liver rRNA between
G4325 and A4326 [34, 45, 46]. There are also some toxins from bacteria that show RIP type-
2 like activities. Corynebacterium diphtheriae and Pseudomonas aeruginosa are two
bacteria that associate a lectin and an EF-2 ADP ribosylase. This type of toxin will then
inactivate EF-2 by binding ADP-ribose covalently, a reaction which is irreversible under
normal cell conditions (see reaction below)[45, 47, 48].
EF-2 + NAD+ ~ ADP-ribosyl-EF-2 + nicotinamide + H+
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2.3.1.3. Other factors influencing RIP activity
The variation in RIP's activity on ribosomes in general can be due to a number of factors
not yet considered, such as resistance to the RIP and/or that there are some cofactors
needed for the RIPs' enzymatic activity [49].
Many studies have been done on the site of recognition and conflicting results have been
obtained which were due to some unexpected activities of RIPs. It seems that some RIPs
do not always inactivate ribosomes of their host plant [43]. In the cases where RIPs were
observed to inhibit protein synthesis of their own cells (e.g. ricin [50] and PAP [51, 52]) it
was shown that the concentrations of RIPs needed to inhibit protein synthesis were much
higher than was needed for cells of non-host species. This also leaves room for speculation
on the involvement of a possible cofactor.
As with most other activity studies, the activity on bacterial ribosomes had conflicting
results. However, the main consensus now is that RIPs do indeed inactivate ribosomes of
E. coli [38, 53-57]. In the case of yeast ribosomes, RIPs always displayed good activity (it
has been proven that Saccharomyces cerevisiae is sensitive to both type-1 and type-2 RIPs
[11]) and newly found RIPs are now generally tested for reactivity on E. coli and yeast
ribosomes [58]. Activity towards other bacterial ribosomes (Streptomyces lividans) has
also been identified [59].
Some studies reported the weak anti-fungal activity of type-1 RIPs but these are so low
that activity may originate from other contaminating proteins [12].
Although all RIPs share the same activity of RNA N-glycosidase activity there seems to be
a difference in substrate specificity as is clearly demonstrated by the above-mentioned
studies. The type-2 RIP, Ricin, is very active on mammalian cells and yeast ribosomes
with no activity on plant and bacterial ribosomes. In contrast, the type-1 RIP, PAP,
inhibits protein synthesis in bacteria, plants, yeast as well as in lower and higher animals
[12]. This difference in target ribosomes, leads us to believe that these two types of RIPs
might have different functions in the native plant.
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2.3.1.4. Alternative substrates of RIPs
Until recently the above-mentioned activities were believed to be the only mechanisms of
RIPs. Ribosomal-RNA was believed to be the only substrate for this protein but it was
since proven that ricin, cinnamonin, luffin and camphorin (also o-sarcin and shiga toxin)
removed the adenosine residues in supercoiled DNA, with no effect on linear DNA [11,
28, 60]. Dianthin 30, PAP and Gelonin were also proved to cut supercoiled DNA
specifically [61, 62]. Later reports suggest that certain RIPs (gelonin) do cut linear DNA
[63].
Barbieri et al. (1996, 1997), tested most of the known RIPs for alternative substrate
affinity. The substrates tested for were DNA, RNA from different sources and poly (A)
RNA. Itwas found that RIPs do interact with these substrates and release an adenosine by
cutting the glycosidic bond. The activity of the RIPs tested, varied but it was proposed (by
Barbieri et al.) that the term ribosome-inactivating protein (RIP) should be changed to
polynucleotide: adenosine glycosidase [64, 65]. In 2000 Barbieri et al. confirmed that
polynucleotide: adenosine glycosidase activity is the sole activity of RIPs on DNA [66].
2.3.1.5. Summary
In short, the activity of RIPs can be summarised as follows: the RIP enters the cell (type-2
RIPs need to be reduced for the A-chain to be active), and they then recognize the GAGA
site on rRNA of 28S ribosome subunit (binds to rRNA with protein-protein binding or
protein-RNA binding [44]). The RIP then cuts the glycosidic bond of the adenine with the
active site in the prominent cleft in the A-chain (N-glycosidase activity). The ribosome is
thereby inactivated and no protein synthesis can continue, resulting in cell death.
2.3.2. The entrance of RIPs into the cell
Type-2 RIPs are more potent than their single chain relatives, because of the B-chain, with
the lectin properties that bind to galactosyl-terminated receptors and allows RIPs to enter
the cell and deliver the A-chain, with enzymatic activities to the cytosol where it
inactivates the ribosomes [11, 20, 67-69]. Thus type-2 RIPs do not require cell damage
before they can enter.
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The RNA N-glycosidase activity for the type-1 RIP and the A-chain of the type-2 RIP is
identical. It is very specific and in rat liver, it recognizes the A4324 base residue on the 28S
rRNA [11, 24, 34, 44].
2.3.2.1. Internalization oftype-2 RIPs
The first step for the RIP in entering the cell is to bind to the receptor site [70]. Type-2
RIPs have a B-chain, which has lectin activity (galactose-specific) which lets the RIP bind
to the galactose containing glycoproteins and glycolipids that are present on the membrane
surface [71]. Most RIPs are glycoproteins and some receptors might interact with these
carbohydrates and mediate entrance into the cell in this way.
Evidence indicates that ricin, and most likely all other type 2 RIPs enters the cell through
endocytosis, and more specifically receptor-mediated endocytosis by way of clathrin-
coated pits, mannose receptors or galacosyl residues. After being internalized by
endocytosis, the vesicle will loose its protein and become an endosome [11].
After endocytosis, the RIP enters the cell via the endosomes, which are then turned into
lysosomes. In the lysosomes the contents can be degraded and the receptors can be
recycled to cell membrane. On this route the toxin must find a way to enter the cytosol. It
seems that some types of receptors might be more effective in delivering the toxin into the
cell than others. The toxin-ligand complex needs an acidic environment (lysosome) to
dissociate and it has been suggested that acidity is needed when ricin enters the cytosol via
the mannose receptor and ricin bound to galactose enters the cytosol via a neutral
compartment [69]. This could be attributed to the specific receptor and its pathway in the
cell. It was also noted that a flux of Ca2+ over the membrane is needed for successful
transport to the cytosol [70].
The internalization of type-2 RIPs can be summarized as follows: The RIP binds to a
receptor on the cell membrane and enters the cell through endocytosis. It is then routed to
intracellular compartments where the active chain is transferred to the cytosol after
dissociation from the binding chain.
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2.3.2.2. Internalization oftype-l RIPs
The transport of type-l RIPs to the cytosol is not clearly understood. It may be that some
of the type-l RIPs enter the cell like type-2 RIPs via their carbohydrate receptors. This
seems to be the exception and might not be true because not all type-l RIPs are
glycoproteins. Saporin S6 is one the most toxic type-l RIPs and is void of all sugars. The
uptake of type-l RIPs seems to be fluid-phase endocytosis. No specific binding of
receptors is required for this uptake [11]. The difference in cytotoxicity of the type-l RIPs
might be ascribed to their different intracellular routes that they take to enter the cytosol.
Some of these routes are discussed later under the antiviral activity in the host plant.
2.3.3. Effects of ribosome-inactivating proteins
The cytotoxicity of RIPs has been studied extensively, and. it is clear that type-l RIPs are
far less cytotoxic than type-2 RIPs. The concentration at which 50% inhibition of protein
synthesis is induced (ICso), for type-l RIPs are in the micro-molar range, whilst in the
pica-molar range for type-2 RIPs. This can be ascribed to the different ways by which the
two RIPs enter the cytosol. From this it could be said that for the RIP to enter the cell
properly it needs a molecule to bind with the cell membrane. The entrance of type-l RIPs
thus needs to be facilitated by either another molecule, physical break in the cell wall or
heightened permeability [72].
Data on the effect of RIPs on different organisms are conflicting and it seems that there is
still a lot to be unraveled about the mechanism of inactivation. For example, in a study on
the effect of barley-RIPs on fungus it was discovered that the RIP needs the help of two
other enzymes (a-glucanase and chitinase) to be able to inhibit protein synthesis [73]. It
was also observed that some RIP's activity are up-regulated or dependant on ATP as a co-
factor [49, 74] and others are up-regulated by specific tRNAs [75]. Osmotic and heat
stress also up-regulates the expression of some RIPs [76, 77].
It can be seen from all these effects that RIPs have a wide range of possible applications,
of which broad-spectrum virus resistance and specific toxicity, might be the most
important. It can also be seen that the exact mechanism of operation and effects of RIPs
have not been elucidated. The study on RIPs is an active field and many of the
mechanisms of inactivation need to be clarified.
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2.3.4. Antiviral activities
The antiviral activities of certain plants have been known since 1925 and in experiments
done by Duggar, cell extracts were mixed with viruses and applied to the leaves of another
species [11, 12,20]. From the observed results it was concluded that plant extracts (RIPs)
acted on the other plants and not on the virus. PAP was the first RIP to be purified and
shown to inactivate the ribosomes of other plants, which was consistent with the other
experiments [78]. Subsequent studies have shown that all type-1 RIPs as well as most
type-2 RIPs have antiviral activity [19].
The antiviral activities of RIPs on DNA and RNA viruses that infect animal cells were
proven the same as in plant viruses where the infected cells are selectively killed [14, 79,
80]. The virus seems to increase the permeability of the cell [72, 81, 82], allowing the RIP
to enter, protein synthesis is halted and the virus is kept from spreading [83]. This
describes the possible mechanism of activity of RIPs on non-host plant or animal cells, but
what happens in plants where these RIPs are present?
2.3.5. Physiological role
All evidence supports the thought that RIPs playa vital role in plant defense. The type-2
RIPs have a different mechanism of defense in that they have the ability to facilitate
movement over membranes with the help of their Binding-chain (lectin) [11]. This activity
the type-2 RIPs makes it highly toxic to lower and higher animals but ineffective towards
bacteria and fungi with their protective cell walls. It is thus believed that type-2 RIPs
(mainly found in seeds) protect the seeds of the host plant from plant eating organisms
[12].
Type-1 and 3 RIPs do not have the ability to move over membranes and is not cytotoxic to
higher animals and invertebrates and it is thus believed that type-1 and 3 RIPs playa role
in plant defense against pathogenic fungus and viruses and not predation [12,39]. It is
questionable whether RIPs have a role in nature as a broad-spectrum pathogen resistance
protein because of its tissue specific expression [84].
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2.3.5.1. Antiviral activity in host plants
The mechanism of virus inhibition in RIP containing plants has not been fully elucidated,
but three proposals have been put forward on how this might occur [12].
1. RIPs act directly on the viral nucleic acid by means of its polynucleotide:
adenosine glycosidase activity [85]. As direct activity on intact viruses are unlikely
because DNAIRNA is physically protected by the virus coat proteins,
deadenylation can only take place as soon as the virus disassembles for
reproduction [12].
2. The local suicide model where RIPs gain access to the cytosol through a break in
the cell wall through damage caused by a virus vector such as an aphid [39, 68].
The spread of the virus to the neighboring cells are limited, as the virus cannot
replicate.
3. The activation of the plants defense mechanism by a RIP [40].
Conflicting opinions exist on the first two proposals because of their time of supposed
activity. After the cell integrity has been breached the endogenous lyases liberated from
the lysosomes will result in almost total nucleic and protein degradation. The observed
contradiction that plants containing RIPs are also susceptible to plant viruses indicates that
there is no direct antiviral activity but rather an indirect activity [12]. It is important to
note that the challenges put to these proposals only have bearing on the mechanism of
action in plants where RIPs are naturally occurring and do not contradict the findings on
the activity of RIPs in cell free experiments.
An alternative to the second proposed mechanism is a local suicide model that is only
activated after the infection has take place. It has been observed that the cell membranes of
mammalian cells become more permeable after virus infection [83, 85]. The
plasmodesmata of plant cells become over-dilated with virus infection and this could also
be possible way by which the RIPs in the intercellular space leak into the cytoplasm of the
cell and by killing the cell prevents further spreading of the virus [11, 39, 72].
With the contradictory results and findings of the first two proposals, the third proposed
mechanism needs more investigation. No such mechanism has yet been observed in RIP-
containing plants but studies on transgenic tobacco expressing recombinant RIPs might
pave the way to a better understanding of the mechanisms involved in antiviral activity
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[12]. Such mechanisms are currently being proposed after the observations in PAP
transgenic tobacco. The proposed mechanism of resistance is independent of the salicylic
acid and pathogenesis-related protein synthesis pathways [69, 87-89]. However, the exact
mechanism for antiviral activity still needs to be elucidated and it is more than likely a
combination of the above-mentioned mechanisms.
2.3.5.2. Anti-fungal activity in host plants
Anti-fungal activity has been observed by some RIPs but unreliable purification
techniques might have given misleading results and it has been suggested that all RIPs
accredited with anti-fungal properties be re-evaluated [12]. Cereal seed RIPs and RIPs that
are inactive on conspecific ribosomes cannot bring about local cell death for virus
resistance [38]. It has been proposed that these RIPs might hold an anti-fungal role as they
are more active on fungal ribosomes than mammalian ribosomes [90].
Logemann et al. transformed tobacco plants to study the anti-fungal activity of the barley
RIP. The transformed plants were resistant to the infection to Rhizoctonia so/ani a
phytopathogenic fungus [91]. In general, plants respond to fungus infection by producing
chitinases and glucanases as part of their systemic acquired resistance (SAR) [92]. These
enzymes inhibit fungal growth by degrading the major structural polysaccharides in the
fungal cell wall [73, 92]. The observation that barley RIPs increased the inhibitory effect
of plant chitinases and glucanases on fungi leads scientists to believe that this is the
mechanism of action for RIPs in plants towards fungus [73]. This at least seems to hold
true for the barley RIPs.
2.4. Applications
The most studied applications of RIPs are their direct use as immunotoxins or as
conjugates with other suitable molecules. The possibilities of this technology are
numerous and the only limitation is that the molecule that binds to the cell must be highly
selective to malignant (cancer or parasitic) cells. In theory then, RIPs can be used as a
'magic bullet' that kills only unwanted cells.
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In agriculture the application lies mainly with transgenic crops where the RIP is used to
give a crop resistance to a range of invading viruses or fungi. The RIPs do not act directly
on the pathogen but on the plant itself and the resistance attained would be broad
spectrum. Discussed below are some specific applications that have been studied thus far.
2.4.1. Immunotoxins
RIPs can be coupled to many molecules that will give it target-specific toxicity, one of
these types of molecules are immunoglobulins (usually monoclonal antibodies). The
coupling of a RIP will then target the RIP to specific cells that will act as the antigen of
that specific antibody. Such a conjugate is called an immunotoxin. The RIP is linked to the
antibody via a disulphide bond or sometimes via a thioether bond. Some interesting
techniques have been developed that exploit the properties of the immunotoxins and many
medical applications have been developed. The field of immunotoxins although interesting
is not relevant to this study [review 93].
2.4.2. Applications in agriculture
The application of RIPs in the agriculture is in principle very simple. The aim is to create
transgenic plants that produce the RIP and can function normally. The ideal situation
would be where transgenic crops are produced that will express the RIP protein in such a
way that they would be resistant to a broad spectrum of viruses [68]. Inmost of the cases
tobacco was used as a model plant to observe the effects on the plant as well as to ensure
that resistance is generated in the plant.
By using the RIP, PAP resistance towards PVX (Potato Virus X, Potexvirus) and PVY
(Potato Virus Y, Potyvirus) was engineered into tobacco and potato plants [68]. Other
groups followed up on these experiments in an attempt to elucidate the mechanism of
resistance. Itwas shown the active site of PAP was needed to give resistance to PVX, but
that the resistance is independent of the salicylic acid and pathogenesis-related protein
synthesis pathways [88]. A less toxic RIP, PAPil was also used in transgenic experiments
and resistance was obtained to PVX, TMV and Rhizoctonia so/ani [89]. The introduction
of a non-toxic mutant of PAP (PAPn) indicated that the activity on ribosomes is a
requirement for resistance of the plant against PVX, PVY and Rhizoctonia so/ani
reiterating the independence of resistance to the salicylic acid pathway [89, 94].
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Lam et al. obtained complete resistance to turnip mosaic virus in transgenic tobacco by
introducing the RIP trichosanthin [95]. Recently, the effects of trichosanthin in transgenic
tobacco were studied in an attempt to unravel the mechanism of resistance. Transgenic
plants generated in this study were resistant to Cucumber mosaic virus (CMV) and TMV.
The mode of action could not be demonstrated [96].
African cassava mosaic VIruS (Geminivirus) resistant Dianthin 30 transgenic tobacco
plants were produced by the Hong et al. from the John Innes institute [97, 98].
Recently, a type-2 RIP, SNA-I' (S. nigra agglutinin I' from Sambucus nigra) was
transformed into tobacco and expression of functional type-2 RIP observed. Resistance to
TMV was attained in transgenic plants but a different mode of action is suspected [99].
To date, there is only one case where transgenic work was continued beyond tobacco or
any other model plant. Kim et al. produced transgenic rice containing a maize RIP (maize-
RIP b-32) [100, 101]. The R2 plants were tested for resistance to Rhizoctonia solani and
Magnaporthae grisea and found more resistant than the non-transformed control plants
[100, 101].
2.5. Dianthin 30
2.5.1. History
The Dianthus genus has been known to contain inhibitors of virus infection since the early
1950's. Scientists from Holland (van der Want, 1951) and Canada (Weintraub and
Gilpatrick, 1952) mixed the sap of Dianthus caryophyllus L. and Dianthus barbatus L.
with plant viruses such as tobacco mosaic and tobacco ring spot and found reduced
symptoms. Ragetli showed in 1957 that the inhibition effect was most likely via the host
plant [102]. More recently the same type of studies were conducted and found that
Dianthin 32 was highly effective in the prevention ofTMV infection [103].
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In 1962, Ragetli and Weintraub were the first to partially isolate and characterise the
"Virus inhibitor protein" now known as Dianthin 30 from Dianthus caryophyllus L. [102,
104].
Stirpe and his team were the first to isolate Dianthin to homogeneity by chromatography
and proposed the name Dianthins for the two RIPs (Dianthin 30 and 32) isolated from
Dianthus caryophyllus L.[105]. The molecular weight of Dianthin 30 was calculated at
29.5 kDa using SDS-PAGE, and an IC50 on rabbit reticulocytes of9.15 ng/ml [105]. From
multiple protein sequence alignments the putative enzymatic site of Dianthin 30 was
shown to be between amino acids 152 and 165 [54].
2.5.2. Properties and activity
Reisbig et al. investigated the tissue distribution of Dianthin 30 and 32 in young and old
Dianthus caryophyllus plants, and found that Dianthin 32 was only present in the leaves
and the young shoots while Dianthin 30 was found throughout the plant. It is also
interesting to note that they found that Dianthins constituted as much as 3% of the total
extracted protein in older plants (Table 2.5)[106].
The Dianthin 30 ORF is 879 bp long and translates to 293 amino acids. From sequence
homologies, the first 23 amino acids might contain a secretion signal. If the polypeptide
undergoes post-translational modification and it is possible that at least the 23 N-terminal
amino acids that are within this signal sequence might be cleaved of and will not be
present in the mature protein. Sequence homology to the C-terminal (last 18 a a) also
indicated a possible vacuole-targeting signal but this remains to be confirmed [11, 107]. In
Figure 2.9. the different predicted forms of Dianthin 30 are depicted. It is important to
note that all referrals to Dianthin 30 in this thesis are to the unmodified pre-Dianthin 30
form.
Initially it was believed that RIPs have no activity on endogenous plant ribosomes [13].
After also investigating the effects of RIPs on their own ribosomes, Stirpe at first came to
the same conclusion [21]. This has later been proven incorrect and some RIPs were indeed
found to be active on their own ribosomes, as Taylor et al. demonstrated for PAP [51] and
Kataoka et al. for MAP [108].
Stellenbosch University http://scholar.sun.ac.za
26
TABLE 2.5
Tissue distribution of Dian thins
Tissue !lg ofRIP/mg of protein
Dianthin 30 Dianthin 32
Old Leaves
Young Leaves
Shoots
Sterns
Roots
Branch Roots
Seeds
12.5 3.9
2.9 1.7
3.0 2.1
17.9
30.2
33.3
10.1
Table adapted from Reisbig et al. (1983) [106].
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Figure 2.9. Schematic representation of the Dianthin 30 gene [11, 107]
Dianthin 30 was believed to have no activity on cell-free ribosomes of E. coli [109], but
with continued study Legname et a/. demonstrated that the expression of Dianthin 30 in a
bacterial system was extremely difficult, but achievable with vectors that have tighter
initiation control [107].
The first "rype-I" RIP to be expressed was ricin A (Ricin without the B chain) and all
conclusions drawn from these expression studies indicated that type one RIPs might have
no activity on E. coli ribosomes. Expression of type 1 RIPs were not so successful and
lead Hartley et al. to investigate further [54]. They found that PAP, PAP-S, Dianthin 30
and 32 inhibit the activity of E. coli 23S ribosomal RNA [38, 54, 59]. The same was also
observed for Dianthin 29 from Dianthus barbatus [55] and for MAP from Mirabilis jalapa
[56]. Dianthin 32 was also observed to have a strong action on yeast ribosomes [103].
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2.5.3. Expression
The first attempts to express Dianthin 30, done by Legname et al. in a bacterial expression
system (pKK233.2), yielded very low concentrations of recombinant protein (20 ug/L)
[110, 111]. Higher concentrations of the rDianthin 30 were however achieved with the use
of the pET/T7 expression system that has tighter transcription initiation control [107].
Expression of a related RIP cDsRIP2 (79% homology to Dianthin 30) from Dianthus
sinesis proved unsuccessful and the possible toxicity of this protein to the E. coli
ribosomes seems the most likely explanation [112].
2.6. Conclusion
It is indisputable that ribosome-inactivating proteins (RIPs) of plants are an interesting
family of proteins. They were first discovered as toxins and this function was exploited
extensively. The reason for their toxicity was only later discovered to be the RNA N-
glycosidase activity that depurinates the 288 eukaryotic mammalian rRNA. It was also
shown that the type-1 RIPs and type-2 RIP's A-chains both have N-glycosidase activity
that cleaves the N-glycosidic bond of adenineaoa of rat 288 rRNA. The site where the
adenine is removed is highly conserved and named the GAGA-site (next to a-sarcin's cut
site on the a-sarcin loop). The removal of this adenine then inhibits the binding of EF-2
thus stopping the translocation of the tRNA (the hydrolyzing of a GTP resulting in the
translocation is catalyzed by EF-2).
More recently it was discovered that RIPs release the adenine of different rRNA as well as
DNA, implicating that the name should be changed to polynucleotide: adenosine
glycosidase. The fact that these new substrates have been found does not change the
current applications of these proteins, it might actually broaden the application.
In the field of agriculture, the possibility of using RIPs in transgenic plants is very alluring
with the reward of possible broad-spectrum virus resistant plants.
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Chapter 3: Expression of Dianthin 30 in bacteria
3.1. Introduction
An intricate part of studying the expression of any protein in transgenic plants is a
detection method for the protein of interest. For this study, it was decided that detection
via polyclonal rabbit antibodies would be the most effective.
Either purified or recombinant protein can be used as antigen but to avoid any cross-
reaction between the polyclonal antibodies and other plant proteins, the route of
recombinant expression was chosen. In a bacterial expression system, a reduced possibility
of epitope similarities to the plant proteins exists as all possible contaminating proteins are
bacterial and the only plant protein is the one that is being investigated.
Two systems for the large-scale expression of rDianthin 30 were considered: a yeast
expression system and a bacterial expression system. The reactivity of Dianthin 32 on
yeast ribosomes was found by Taylor et al. to be >8 times higher than Ricin and >14 times
higher than PAP [103]. Considering these data and the sequence similarities between
Dianthin 30 and 32, yeast expression was not attempted for Dianthin 30 [103]. The
expression of Dianthin 30 has largely been unsuccessful and various reasons are given for
this. The toxicity of the protein to ribosomes is the most likely explanation. However,
some researchers were able to claim limited success with the expression of Dianthin 30 in
bacterial expression systems [107, 110, 111].
Legname et al. (1991) was first to attempt the expression of rDianthin 30 [110]. They
expressed 20 ug/L rDianthin 30 in JM109 E. coli cells using the expression vector pKK
233.2. In 1995, Legname et al. described the expression of Dianthin 30 and a deletion
mutated Dianthin (~255-270) using the pET/T7 expression system with BL21(DE3) and
BL21(DE3)pLysS E. coli cells. They were able to express Dianthin 30 (first 23 N-terminal
a a removed) to a level of 10mglL [107].
For recombinant expression, in vitro expression was also considered. Commercial
expression systems are available that promises high-level expression in a cell-free
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environment (e.g. TNT from Promega). The drawback to these systems are that they are
very expensive and with the observed activity of RIPs on ribosomes of various organisms
combined with the limited success already achieved in an in vivo expression system [110],
it was decided not to attempt expression this way. Wheat germ expression was also
discarded as a possible option because of the inhibition of the native RIP, tritin, that
inhibits expression [113].
The expression vector pET14b was chosen, mainly for its T7 promoter driven expression
as well as its Histidine-tag [114]. The vector has the advantage that with the help of an in
frame NdeI restriction site, a gene of interest can be cloned behind a 6x His-Tag that could
be helpful during detection and purification of the expressed protein. One more advantage
of using the His-tag is that no ATG start codon is needed as the start codon is already
situated 8 bp from the ribosomal binding site. One drawback to pET14b is that it does not
contain many restriction sites to clone into and cloning strategies need to be planned
carefully to ensure success.
The mechanisms utilised by the pET expression systems are illustrated in Figure 3.1. The
DE3 E. coli cell line that was used contains a lac promoter driven T7RNA polymerase as
well as a repressor gene in the genome that allows for stricter expression (i.e. less basal
expression) than lac promoter driven systems. The cell line BL21(DE3) was used. For
even more stringent expression the BL21(DE3)pLysS cell line was used.
BL21(DE3)pLysS cells contain an additional plasmid, pLysS that down regulates the T7
RNA polymerase that helps with the expression of toxic genes. It is thus clear from Figure
3.1. that induction with IPTG will lead to the production of T7 RNA polymerase that can
then in tum transcribe the gene of interest on the introduced plasmid that contains a T7
promoter for translation. Inour case it was pET14b [114].
The strategy was to utilize the His-tag for detection and purification purposes, therefore a
cloning strategy was planned around it. Dianthin 30 has an internal XhoI site and that
made directional cloning into pET14b difficult. However, with the 5' overhang
compatibility of XhoI and San it was decided to design a 5' primer with the NdeI
restriction site and a 3' primer with the San restriction site. With NdeI and XhoI being so
close to one another, this made the restriction enzyme digestions extremely difficult but its
was nevertheless attempted and achieved.
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Figure 3.1. This diagram illustrates the working of the pET system. The diagram
illustrates the mechanism in an E.coli strain containing the DE3 construct. The
insert shows the mechanism of down regulation attained when using E.coli strains
containing the pLysS plasmid [115].
To visualize the product of expression the His-tag was used in Western blots of SDS-
PAGE gels. There are a number of products available to detect or purify 6xHistidine-
containing proteins - they use either antibodies or nickel. The nickel based systems are
more cost effective and are just as sensitive as antibody based products. For these
expression experiments the KPL ExpressDetector™ Nicke1-HRP Chemiluminescent
BlottingKit was used in the detection of His-tag containing proteins.
3.2. Experimental procedures
3.2.1. Cloning and sequencing ofDianthin 30 in pGEM T Easy.
As starting material a Dianthin 30 pGEM T Easy clone was used [5]. To validate
the clone it was first sequenced with the SP6 primer (ABI prism® 3100 genetic
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analizer). For comparison the sequence for Dianthin 30 was obtained from
GenBank under accession number X59260 [110].
Primers were designed to amplify the entire sequence of Dianthin 30 as well as
incorporating restriction enzyme sites on the 5' and 3' ends that would facilitate
the cloning into pET14b. The primers were designated pET-For: 5'-GG GAG CAT
ATG AAG ATT TAT TTA GTG G-3' with the recognition site for NdeI
underlined, and pET-Rev: 5'-AA GTC GAC TCA AAG CAC ATC AGC-3' with
the recognition site for SalI underlined. The Tmfor this primer set was calculated at
63°C using a Nearest Neighbor algorithm [116].
Using PCR [117], (16 mM NR.S04, 67 mM Tris-HCI pH 8.8, 0.01% Tween-20,
1.5 mM MgCh, 10 mM dNTP, 5 U DNA polymerase and 10 mM Primer) and the
pET primers (TA 58°C) Dianthin 30 was amplified from the pGEM-T Easy
Dianthin 30 clone [5]. Buffers and DNA polymerase used was from Bioline and
dNTPs from Promega. The resulting PCR product was then re-cloned into pGEM
T Easy. Ligations were performed as recommended by manufacturer [118]. The
ligation product was then transformed into competent E. coli DH5a cells, which
were rendered competent with the CaCh method [119]. Transformations were done
as described by Promega technical manual [118]. The new plasmid was named
pGEM-Dian.
3.2.2. Cloning Dianthin 30 into pET14b
pET14b, derived from the original vector developed by Studier and Moffatt in
1986, was obtained from Novagen [120, 121, 122]. pGEM-Dian was digested with
NdeI and SalI and pET14b with NdeI and XhoI restriction enzymes. With the NdeI
and XhoI restriction sites so close to one another partial digestion of pET14b can
be expected. The fragments resulting from the digest of pGEM-Dian were then
separated on a 1.4% agarose-TAE gel (Figure 3.3) and the insert (Dianthin30)
purified by centrifugation through synthetic glass wool (5', 12 000 g).
The NdeI and SalI flanked Dianthin 30 was ligated into the NdeI and XhoI digested
pET14b. All resulting colonies were screened with PCR and RE digests. To
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confirm the integrity of Dianthin 30 in pET14b, it was sequenced with a T7
promoter primer and a T7 terminator primer. The T7 terminator primer was
designed from the sequence of pET14b (5'-GCTAGTTATTGCTCAGCGG-3')
[115]. The newDianthin 30 containingplasmid was referred to as pET-Dian.
3.2.3. Expression in E. coli.
pET-Dian was then transformed onto BL21(DE3) and BL21(DE3)pLysS
competent cells. These cells were rendered competent using the RbCI method
[123].
One milliliter saturated overnight BL21(DE3) and BL21(DE3)pLysS, pET-Dian
cells were inoculated into 50 mL LB media (100J.lg/mLampicillin). The following
expression studies were performed:
1) Culture was induced at time 0 with 0.4mM IPTG and samples taken at 0, 2, 4
hour after induction (Figure 3.6.).
2) The same procedure as in 1but with 0.8mM IPTG.
3) The culture was allowed to grow to an OD6oo of 0.8 before induction with
0.4 mM IPTG. To establish if the protocol is indeed capable of giving positive
results a positive control was included. The positive control was the Hsp70
gene from Grapevine Leafroll associated virus 3 in pET14b obtained from M-J
Freeborough from the Institute forWine Biotechnology (Figure 3.7.).
4) Identical to 3 but add 100 ug/ml, rifampicin 30' after induction - only for
BL21(DE3)pLysS cells.
A growth curve companson was drawn between BL21(DE3) pET14b and
BL21(DE3) pET-Dian (see Graph 3.1.).
3.2.4 SDS-PAGE and Western blots
Crude protein extracts were prepared and denatured at 95°C for 2min in 2x loading
buffer (0.125 M Tris-HCI, pH 6.8, 4% SDS, 20% Glycerol, 10% ~-
mercaptoethanol, 0.25% Cresol red). Denatured protein was then separated on a
discontinuous PAG (6% stacking and 12% resolving) in electrode buffer (250 mM
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Tris, 192 mM Glycine, 0.1% SDS, pH 8.3) and Coomassie staining protocol as
described by Promega [124].
Soluble and insoluble protein was purified from other cell debris as follows:
Cells were harvested and resuspended in TNE buffer (20 mM TRIS; 50 mM NaCl;
1mM EDTA, pH 8, 0.5 mM DTT) at a ratio of 1 g : 7 mL. When cells were fully
resuspended, 10 mg/mL lysozyme and 50 mM PMSF were added and incubated
for 30 min on ice and vortexed every 10min. Three freeze/thaw cycles for 30 min
at -80°C and 37°C were performed. The sample was then frozen overnight at -
80°C. Samples were sonicated 90" (50% duty micro tip 5) on ice in 1.5 mL
volumes in 2mL microcentrifuge tubes and centrifuged for 10 minutes maximum
rpms. The supernatant containing the soluble proteins was decanted from the
pellet. The pellet was washed in TNE buffer and 2% Na-DOC, and incubated for
10 minutes and centrifuged. The supernatant containing soluble protein was kept.
The pellets were resuspended in TNE buffer with 0.5 mM DTT and 0,4% Sarcosyl,
and vortexed 30 min. Sample was spun down maximum rpms for 10min,
supernatant contained insoluble proteins.
For Western blots, SDS-PAGE gels were electroblotted to PVDF-membrane (1
amp, 6 V, 30'). The KPL ExpressDetector™ Nickel-HRP Chemiluminescent
Blotting Kit was used to detect His-tag proteins on the membrane. No alterations
were made to the protocols and the carbonic anhydrase molecular weight marker
(30 kDa) was used as the positive control [125].
3.3. Results and discussion
3.3.1. Cloning and sequencing of Dianthin 30 in pGEM T Easy.
To validate the clone from K.L Wilsen it was first sequenced with the SP6 and T7
primers. The results indicated a four base pair mutation affecting the stop codon of
Dianthin 30. From these results, it was clear that the 3' primer was mutated and
new primers were then designed to aid cloning into pET14b.
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The pnmers that were designed were called pET-For and pET-Rev and they
incorporated NdeI and SalI restriction sites respectively. With these restriction sites
Dianthin 30 could be directionally cloned into pET14b taking into account that the
SalI and XhoI restriction sites have compatible overhangs. See Figure 3.2 for
restriction map ofpET14b.
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a 1(24)
Hind 111(29)
Bpu 1102 1(458)
BamH 1(510)
Xho 1(515)
Nde 1(522)
Nco 1(580)
Xba 1(619)
BgllI(6n)
SgrA 1(71B)
Eam11051(3676)
pET-14b
(4671 bp) Eag 1(1247)
Nru 1(1282)
1(1360)
BspM 1(136:2)
Sap
B5t11071(2554)
BsaA I(2535)
Tth 111 1(2528)
85mB 1(2424)
Pvu 11(2374)
34
b r--------------------------------------------------------,
17 promoter primlr'6SJ34;
....!!t.!!... T7p<omo .... ~ ~ ...!!!!...
ACA1CTCQlTCCCCCQAUTTAATACCAC1CACTATACQCWCCACAACCQTTTCCCTCTAQl.u.TAATTTTCTn.u.cnTAAWGiCACA
NCDI His-T., N::I.t :<hoi s.nH I
TAUCCATc.ACCACCCAnATCATtA1CATCACACCACCCQCCTICTCCCCCCCGCCACCCATATCCTCQACQlTCCGiCCTCCTAACA.UQCCCCA
... tCly ...... WlOWI01110II1.~1.~1.a-1...c [ylOllY•• p,..,.,G' r•.rtII.".tL_lu .. ~~."I""a& •• L~,U .... ,
Bpu11021 thrombin- T7 termin.tor
~.u.cCTCACn.eeTGCTCCCACC'C1QACCAATAAC' ... aT.u.cca;"Wïlicr;fcTAilCQiQfe"iliïliiffTTTTc
LYI.I ......_I~~AI ........ oT";l'.QI~QlftIlo4
TI "rmi'lator primlr .6Q337-3
pET.14b clonin!1expression region
Figure 3.2. a) Restriction map of pET14b. b) Sequence and RE site details of
expression region indicated in a) with a black arrow [115].
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Using PCR and the pET primers, Dianthin 30 was amplified and re-cloned into
pGEM T Easy. This was done to ensure that the restriction enzyme digests of the
flanking regions of Dianthin 30 could be monitored. pGEM-Dian, the resulting
plasmid was confirmed with restriction digests (see Figure 3.3.).
1kb
Figure 3.3. pGEM-Dian digested with NdeI and San and visualised on an
ethidium bromide stained, 1.4% agarose-TAE gel. Lane 1 1 kb+ molecular marker
(GibcoBRL), Lane 2 Digest product.
3.3.2. Cloning Dianthin 30 into pET14b
Two important advantages of the pET14b expression vector are the T7 promoter
driven expression and the His-tag. The start codon is preceded by sequence coding
for a 6xHis-tag and thrombin site with the ribosome-binding site (RBS) 8 bp
upstream. The 5' overhangs of XhoI and Sail are compatible and because Dianthin
30 has an internal XhoI site this strategy was chosen as this was the only way of
directionally cloning Dianthin 30 into pET14b.
With the vector quantity kept constant a positive correlation was found with the
amount of insert and number of colonies formed. After numerous isolations only
one colony was found that tested positive with PCR and RE digests (see Figure
3.4.). This was due to the fact that the two restriction sites used were too close to
each other which was to be expected (see Figure 3.5.).
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Figure 3.4. Figure shows RE digests of pET-Dian. In lane 1 and 7 1 kb+ marker,
Lane 2 pET-Dian digested with Ndel, Lane 3 pET-Dian digested with SalI, Lane 4
pET-Dian digested with BamHI, Lane 5 pET14b digested with BamHI, Lane 6
pET -Dian NdeI and SalI.
pET-Dian
5553 bp BamH 1(1367)
Nde 1(1405)
Figure 3.5. Restriction map of pET-Dian.
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Restriction enzyme digests yielded fragments of the expected sizes and indicated
that the insert might be Dianthin 30. The sequencing results of Dianthin 30 in the
pET14b vector with the T7 promoter and the T7 terminator primers confirmed the
results of the RE digests. The T7 terminator primer was designed on the sequence
of the pET14b, vector to have a TAof 55°C. The sequencing results showed no
mutations in the sequence of Dianthin 30. With the sequence of Dianthin 30
confirmed in pET14b the new plasmid pET-Dian could be used for expression in
various E. coli strains.
3.3.3. Expression in E.coli, SDS-PAGE and Western blots
The confirmed vector pET-Dian was transformed into BL21(DE3) cells made
competent with the RbCl method. As explained earlier, only cell lines containing
the DE3 construct can be used for expression of vectors driven by a T7 promoter.
For these expression experiments, a protein at 32 kDa is expected and not 30 kDa
as Dianthin 30 is now preceded by the His-tag and the thrombin site in the
expression vector.
For the first expression experiment, 1mL overnight culture was inoculated in fresh
media containing selection antibiotics and 0.4 mM IPTG. Samples were taken at
regular intervals (0, 2, 4 hours) and processed for SDS-PAGE separation and
Coomassie staining (see Figure 3.6.).
Figure 3.6. Coomassie stained SDS-PAGE of crude protein extracts of E. coli
(BL21(DE3)) containing pET14b and pET14b-Dian. Lanes 1, 3, 5 and 7 are
pET14b-Dian, uninduced, 4 h, 2 h, and 0 h. Lanes 2, 4, 6 and 8 are pET14b
uninduced, 4 h, 2 h, and 0 h.
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Cells from the expression studies were boiled in loading buffer to denature proteins
and separated in a discontinuous PAG. The proteins in the PAG were then stained
with Coomassie brilliant blue for visualization. From the fIrst expression
experiment (see Figure 3.6.) it was clear that no expression of induced protein is
visible in the protein band patterns. Itmight be that the expression was too weak to
be detected by the insensitive Coomassie staining technique or that the expression
was unsuccessful.
A growth curve comparing the growth of BL21(DE3) cells containing the two
different plasmids pETI4b and pET-Dian was drawn (see Graph 3.1). From this
graph it is clear that there is a slight difference in final OD600 reading between
induced and uninduced samples, with the induced samples not reaching the same
optical density.
GRAPH 3.1 Absorbance at 600 nm of Dianthin 30 clones
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To test the expression efficiency, the experiments were repeated with a higher
concentration of IPTG (0.8 mM), but from the Coomasie stained SDS-PAGs no
induction was detectable.
The protocol for expression was then changed as the culture was allowed to grow
to an OD600of 0.8 before it was induced with 0.4 mM IPTG. To confirm that the
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protocol was able to produce results a positive control was added. The positive
control (Hsp70 gene from Grapevine Leafroll associated Virus 3) from M-J
Freeborough yielded a protein at 59 kDa, which is at the expected size. Again no
detectable induction was observed except for the positive control (see Figure 3.7.).
Successful expression from the positive control suggested that the levels of
Dianthin 30 expression might be too low to be detected with the Coomassie
staining technique or that the abundance of other proteins in the crude cell extracts
masked the visualisation of any expression product. The possibility that the
expression product is toxic to the bacterial cells was also considered and
expression experiments were redone with BL21(DE3)pLysS cells that has the
ability to deal with toxic gene products better as these cells have more control over
the induction of expression. The results however were the same.
1 2 3 4 5 6 7 8 9 10
Figure 3.7. Coomassie stained SDS-PAGE crude protein extracts of E. coli
(BL21(DE3)) containing pET14b (Negative control), pET14b-Hsp70 (Positive
control) and two samples ofpET14b-Dian. All before and after induction. Lanes 1
and 10 is the Molecular weight marker from Amersham, Lanes 2 and 6 pET14b-
Hsp70 (Pos) uninduced and induced. Lanes 3 and 3 pET14b (Neg) uninduced and
induced. Lanes 4 and 5 pET14b-Dian samples uninduced and Lanes 8 and 9
pET14b-Dian samples induced.
30
Another induction strategy was used where rifampicin was added to the culture, 30
minutes after induction. Rifampicin inhibits transcription and thus ensures that all
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cell function focuses on expression of existing mRNA in the bacterial cell and no
additional mRNA is produced [126].
Soluble and insoluble proteins was purified from the harvested cells in the
expression studies and separated with SDS-PAGE. The results again did not
indicate a clear induction (see Figure 3.8.).
Figure 3.8. Coomasie stained SDS-PAGE gel; red arrow indicates position where
Dianthin 30 is expected. Lanes 1 and 8 Low Molecular weight marker, lane 2
pETI4b uninduced, lane3 pETl4d-Dian uninduced, lane4 pETI4b induced soluble
fraction, lane 5 pETI4b induced insoluble fraction, lane 6 pETl4d-Dian induced
soluble fraction, lane 7 pETl4d-Dian induced insoluble fraction.
With the advantages of the His-tag, it was possible to do Western blots to detect
smaller quantities of the expressed protein. The KPL ExpressDetector™ Nickel-
HRP Chemiluminescent Blotting Kit was used to detect the His-tag on the N-
terminal ofrDianthin. Carbonic anhydrase (30 kDa) was used as molecular weight
marker and positive control for detection with nickel HRP. The nickel binds to the
zinc binding motifs of carbonic anhydrase that contains high concentrations of
histidines. Very weak expression of Dianthin 30 was detected by the HRP (see
Figure 3.9.). From the figure, a faint band can be seen at the expected size of
32 kDa (30 kDa and the addition of the His-tag with the thrombin site), as well as
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the marker at of30 kDa. The faint band seen here was reproducible but attempts to
increase the concentration failed.
Figure 3.9. Chemiluminescent Western blot using Nickel-HRP to detect His-tag.
The blue ellipse shows faint band that consistently detected. Lanes 1, 2 and 9 Low
Molecular weight marker, lane 3 pET14b uninduced, lane 4 pETl4d-Dian
uninduced, lane 5 pET14b induced soluble fraction, lane 6 pET14b induced
insoluble fraction, lane 7 pET14d-Dian induced soluble fraction, lane 8 pET14d-
Dian induced insoluble fraction.
With all the permutations in the expression parameters and cell lines the best
results were obtained with the BL21(DE3)pLysS cell line in the induction protocol
were rifampicin was added 30 minutes after induction. However, the results
obtained was far from being adequate to be used as antigen for antibody production
- this was in line with the weak expression observed by Legname et al. [107]. The
most logical conclusion from these results would be that the bacterial ribosomes
are extremely sensitive to Dianthin 30 as also found by other researchers [38, 54,
59].
The low level of expression of Dianthin 30 in a bacterial expression system leads
us to conclude that expression in prokaryotes will not lead to Dianthin 30
expression levels that could be used for antibody production without extensive
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purification. However, the possibility does exist that an eukaryotic expression
system might be better equipped to deal with this toxicity, and it needed to be
investigated. In chapter 4, the expression of Dianthin in insect tissue culture is
described.
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Chapter 4: Expression of Dianthin 30 in insect tissue culture
4.1 Introduction
Previous attempts at expressing Dianthin 30 in a bacterial expression system were described
in Chapter 3. Very low levels of expression were observed that were inadequate to be used as
antigen for the production of antibodies. From these results, it seemed that the prokaryotic
system was unable to deal with the toxicity of the gene product and alternative methods of
expression were investigated.
A eukaryotic system was considered that would be better equipped to deal with the toxicity of
Dianthin 30 in a foreign cell environment. There were three considerations for these
expression studies: plant, mammalian and insect tissue culture.
The expression of foreign proteins in plant tissue culture has only recently come to the
forefront with the advances in biotechnology and plant tissue culture techniques. It is an
option to consider for future applications [127]. A major drawback of this system would be
the difficulty to purify the recombinant protein to homogeneity, i.e. to eliminate
contaminating plant proteins for antibody production.
Mammalian tissue culture was not considered since it requires considerable technical skill
and equipment that we did not have to our disposal.
The expression of Dianthin 30 in a eukaryotic system was attempted in insect tissue culture
for a number of reasons. Although RIPs have never been expressed in insect tissue culture the
ability of insect cells to deal with toxic genes generally is better than that of bacteria. With
the use of a virus vector these expression experiments are less time consuming and simpler to
perform than mammalian tissue culture. It also has the added advantage that it has less chance
of contributing contaminating proteins than a plant tissue culture expression system.
For the expression III insect tissue culture, the BAC-TO-BAC™, baculovirus expression
system developed by Monsanto (see Figure 4.1.), now distributed by Invitrogen was chosen
[128]. This rapid and efficient system makes use of the site-specific transposition of an
expression cassette into the baculovirus shuttle vector (bacmid) propagated in DHI0BAC
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E. coli cells. The bacmid propagates as a large plasmid that contains all the essential elements
for the virus to be functional as well as a kanamycin resistance gene. The plasmid also
contains the lacZa gene with an attachment site for the Tn7 bacterial transposon in the N-
terminal region. This can thus indicate if the transposition event did indeed occur. The
bacterial plasmid pFASTBACI contains the transposition elements and the expression cassette
and is used to clone the gene of interest.
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Figure 4.1. a) Restriction map of pFASTBACI. b) RE and primer binding details of
multiple cloning site [129].
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The expression cassette between the left and right arms of Tn7 consists of a GmTgene, the
polyhedrin promoter from Autographa californica nuclear polyhedrosis virus (AcNPV), a
multiple cloning site and a SV40 poly(A) region. Recombinant bacmid DNA can be used to
transfect Sf21 insect cells from the fall armyworm, Spodoptera frugiperda to produce
recombinant baculoviruses. Once the cells are infected they produce mature recombinant
virus particles that infect neighboring cells and the gene of interest is thus expressed during
this process. The gene of interest is under the control of the polyhedrin promoter (AcNPV)
that is abundantly expressed in the late stages of infection [129].
4.2. Experimental procedures
4.2.1. Cloning of Dianthin 30 into pFastBac1
As starting material the pET -Dian clone was used. With the T7 promoter primers and
pET Rev primers, Dianthin 30 with the His-tag was sub cloned into pGEM-T Easy.
Dianthin 30 with the His-tag was then liberated from pGEM-T Easy Dianthin by
digesting with Notl and cloned into pFASTBAC1 (see Figure 4.3.). To confirm the
insert and orientation, pFASTBAC1-Dian was digested with Xbal and Bamffi (see
Figure 4.4.). pFASTBAC1-Dian was sequenced with a Dianthin 30 internal reverse
primer (391Rev)( 5'-CTATCGCCTGGT AATCTTCC-3 ').
4.2.2. Expression in insect tissue culture
The pFASTBAC1-Dian plasmid was used for the transformation of competent
DH10BAC E. coli cells as described by the manufacturer [129]. White colonies
contain the expression cassette as the transposition disrupted the lacZ gene.
Recombinant bacmid DNA was isolated as recommended and used for the
transfection of Sf21 insect cells. The transfection of the bacmid DNA was aided with
the addition of CELLFECTIN, a lypolysing agent that aids the movement of the
bacmid DNA over the cell membrane. Recombinant virus particles were isolated and
used to infect Sf21 insect cells. The growth medium used for the cells was TC 100
with 10% FCS. Infected insect cells were harvested at 4 days [129]. For a summarised
protocol see Figure 4.2.
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Figure 4.2. Summary of protocol for the generation of recombinant baculoviruses
and gene expression with the BAC-TO-BAC® Baculovirus expression system [129]
4.2.3. SDS-PAGE and Western blot analyses
From the harvested insect cells, crude protein extracts were prepared and denatured at
95°C for 2min in 2x loading buffer (0.125 M Tris-HCI, pH 6.8, 6 M Urea, 1 mM
DTT, 0,25% Bromophenol Blue). Denatured proteins were then separated on a
discontinuous SDS-PAGE (6% stacking 12% resolving) in electrode buffer (250 mM
Tris, 192 mM Glycine, 0.1% SDS pH 8.3).
Western blots were performed with the ECL Plus Western blotting detection system
from Amersham LIFE SCIENCE and Anti-His, Peroxidase (mouse monoclonal
antibody) from Roche. All procedures were performed as recommended by
Amersham [130].
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4.3. Results and discussion
4.3.1. Cloning of Dianthin 30 into pFastBac1
For the expression of Dianthin 30 in insect cells, it was important to have a tag to
trace the protein as it is being expressed. The His-tag from the pET-Dian plasmid was
utilized by amplifying the entire sequence of Dianthin 30 with the pET-Rev primer on
the 3' end, and the T7 promoter primer on the 5'end. For restriction map see
Chapter 3 Figure 3.5. The amplified sequence was then sub cloned in to pGEM- T
Easy to acquire flanking NotI sites that were then used for cloning into pFASTBACl.
See Figure 4.3. for restriction map of pFASTBAC1-Dian. The insert and orientation
was confirmed with RE digests (See Figure 4.4.). pFASTBAC1-Dian was sequenced
with an 20 bp internal primer (391 Rev) that bound at bases 531 to 550 of Dianthin
30. From the sequencing results it was clear that Dianthin 30 was intact and in the
right orientation in pFASTBAC1.
Tn7L Fllntergenic Region
BamH I (4269
Amp'
Dianthin 30
pFASTBAC-Dian
5806 bp
Gmr Tn7R
Figure 4.3. Restriction map ofpFASTBAC1-Dian.
4.3.2. Expression in insect tissue culture
pFASTBAC1-Dian was transformed into competent DH10BAC E. coli cells for the
transposition to take place. White colonies, indicating that transposition took place
since it disrupted the lacZ gene, were detected after 48 hours. Bacmid DNA was
isolated from these colonies and used with the lypolising agent, CELLFECTIN to
transfect Sf21 cells. After 4 days recombinant virus stock was collected from the
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transfection experiments and used to infect Sf21 cells for the expression. After 4 days,
the cells were infected as judged visually and harvested.
1kb
Figure 4.4. RE-Digest of four putative pFASTBAc1-Dian plasmids. Lanes 1 and 10
1 kb+ molecular marker, lanes 2, 3, 4 and 5 are BamHI digests of samples 1-4 and
lanes 6, 7, 8 and 9 the XbaI digests. From this digest it is clear that only sample 1
(lanes 2 and 6) contains the insert and that it is in the right orientation (See Figure 4.3.
forRE map).
4.3.3. SDS-PAGE and Western blot analyses
An anti-His antibody detected very low levels of expression in the insect cells tissue
culture. In Figure 4.5., it is clear that the antibody detected a protein at the expected
size but that the concentration of this protein is very low. Again the toxicity of the
protein might be blamed, but with no reference study except for the positive controls
of unrelated proteins, it was difficult to say exactly why such low concentrations were
expressed.
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Figure 4.5. Chemiluminescent Western blot using Anti-His Peroxidase to detect His-
tag. The blue ellipse shows faint bands that were detected. Lanes 1 and 8 Rainbow
Marker (Amersham), Lanes 2 and 3 supernatant and cell protein respectively. Lanes 4
to 9 supernatant and cells of two other proteins that do not contain His-tags (Negative
controls).
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Chapter 5: Peptide design and antibody analysis
5.1. Introduction
The low concentration recombinant protein obtained from the bacterial and insect tissue
culture expression experiments was insufficient to be used as antigen for the production of
antibodies. As an alternative to expressing the whole protein and using it as the antigen, a
peptide may be synthesized that would mimic an epitope on the native protein. With the
advent of the computer age came the opportunity to predict the properties of proteins
based on their amino acid sequence and this is particularly useful in the prediction of the
possible antigenic sites on the mature protein of interest.
There are various algorithms available on the Internet and in Software packages that help
with these predictions. The first step in predicting which sequence areas are the most
antigenic, would be to determine which parts of the protein are on the outside and
subsequently available for interaction with the antibody. Using an algorithm that predicts
the hydrophilic areas in the protein, these areas can be identified. This would not be
critical for our purpose, as we will analyse only denatured protein. Other algorithms
predicting the flexibility and antigenicity can also be useful to predict peptide sequences
that would be antigenic [131, 132].
The longer the synthesised peptide the greater the conformational similarity is to the native
protein. This increases the chance that antibodies raised against the peptide as antigen
would result in antibodies that would recognise the natural protein. The smallest antigenic
peptide is between 5 and 8 amino acids - thus a peptide of 15-20 amino acids would at
least contain 1 epitope and would adopt a limited amount of conformation [133].
The peptide selected must be soluble in an aqueous buffer for conjugation and use in
biological buffers. The selection of a sequence in the hydrophilic regions should produce
peptides that are soluble. Hydrophobic residues like W, V, L, I, and F, must still be
avoided and the selected peptide must contain as little as possible of these amino acids.
Multiple glutamine residues must also be avoided as they could form hydrogen bonds
between peptide chains and thus cause insolubility of the peptide [133].
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The inclusion of proline (P) and tyrosine (Y) in the peptide sequence would enhance the
immunogenic properties of the peptide. Proline can adopt a cis-amide bond structure that
gives the peptide a structure that could represent the natural conformation of the epitope
more accurately. Tyrosine is a large amino acid that with its ring structure can also induce
structural motifs that would contribute to the success of the peptide to simulate the epitope
of the natural protein. Transmembrane and glycosylation sites should be avoided, as these
sites may be modified or unavailable in the natural protein [133]. The sequence chosen
must also not have sequence similarities to other proteins as this will lead to cross reaction
of the antibodies to these proteins.
A peptide (10-20 a a) by itself is too small to raise an immune response and needs to be
coupled to a carrier protein such as BSA or KLH for the immune system of the rabbit to
respond to the antigen [131].
The serum collected from the rabbits at different intervals after inoculation with the
antigen can be used in Western blots to detect the protein of interest.
5.2. Experimental procedures
5.2.1. Selection of a suitable peptide sequence in Dianthin 30 and antibody
production.
The amino acid sequence of Dianthin 30 was obtained from GenBank (Accession
number X59260). The sequence was submitted to three independent peptide
synthesis companies for predictions on which areas would be most suitable for
peptide synthesis for the purpose of raising antibodies. Their proposals for the most
likely antigenic peptides are set out in Figure 5.1.
From these results it appears that there are three possible areas from which
peptides can be synthesized as potentially useful antigen. Although the algorithms
are useful they still are just predictions and do not take into account any post
translation modification. With the use of the web based algorithms TargetP V1.0
Prediction Results and PSORT, a signal sequence was predicted on the N-terminal
of Dianthin 30 [133-135]. For the purposes of a potential antigen, the a a sequence
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of residues, 174-189, which was also the first prediction by Bio-Synthesis and
Princeton Biomolecules was chosen.
Bio-Synthesis Incorporated was contracted to synthesise the Dianthin 30 specific
peptide and to conjugate it to a carrier protein for the immunisation of 2 rabbits.
The antibody production of the two animals was then verified with ELISA testing
by Bio-Synthesis. The purity of the peptide was determined by Laser Desorption
Mass Spectrometry.
Dianthin 30 protein sequence
MKIYL VAAIA WILFQslsSWT TDAAT AYTLN !JANpSASQYS SFLDQIRNNV 50
RDTSLIYGGT DVEVIGAPST TDKFLRLNFQ GPRGTVSLGL RRENLYVVAY 100
LAMDNANVNR AYYFKNQITS AELTALFPEV VVANQKQLEY GEDYQAIEKN 150
AKITTGDQSR KELGLGINLL ITMUDGVNKK VRVVKDEARf LLIAIQMT AE 200
AARFRYIQNL VTKNFPNKFD SENKVIQFQV SWSKISTAIF GDCKNGVFNK 250
D FGFGKVR OAKDLOMGLL KYLGRPK~SS IEANSTDDTA DVIJ 293
~- Diagnostic~ Princeton Biomolecules Bio-Synthesis
Figure 5.1. Protein sequence of Dianthin 30 showing the different peptide
sequence predictions of three companies. The sequence used in highlighted in red.
5.2.2. Western blot analyses
Antibody binding in the serum received from Bio-Synthesis was verified using the
peptide as the positive control in a suitable detection system (ELISA). The next
step was to determine if the antibodies would recognise native Dianthin 30.
Dianthus caryophyllus plants from different cultivars were used as positive
controls and tobacco and Dianthus barbatus (a related species) as negative controls
in the Western blots that were used to optimise the conditions for the blots.
Crude protein extracts of the plants were made by grinding the material up in an
extraction buffer (0.5 M Tris-HCl, pH 7.4, 0.5% p-Mercapto-ethanol and 1%
Triton XIOO) and centrifuged at 16000 g for 10 minutes. The supernatant was then
52
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loaded onto a discontinuous (6% - 12% comp) SDS-PAG for electrophoresis with
6x Loading buffer (0.750 M Tris-HCI, pH 6.8, 3% SDS, 40 mM DTT, 30%
Glycerol, 0.25% Cresol Red).
The separated proteins were then transferred to a PVDF membrane as suggested by
the manufacturer, MSI [136]. The procedure that was followed for the western
blots was similar to the one described in Chapter 4 of this thesis [130]. The only
difference was that the KPL substrate LumiGlowas used as the substrate for HRP.
To optimise the western blots, a dilution series of the primary antibody was used to
detect Dianthin 30 that ranged from 1:500 to 1:106. The sera of the two rabbits
were also compared.
5.3. Results and discussion
5.3.1. Selection of a suitable peptide sequence in Dianthin 30 and antibody
production.
The peptide predictions from the different companies highlighted three areas that
would possibly be antigenic. Using the TargetP V1.0 Prediction Results and
PSORT web based algorithms, a signal peptide was predicted in the first 23 N-
terminal amino acids of Dianthin 30, which correlates with the findings by
Legname et al. [107, 133-136]. Dianthin 30 also contains a putative vacuole target
sequence on the 16 C-terminal amino acids [107]. The existence of these signal
peptide sequences and the possibility that they might be modified in the mature
protein makes these areas undesirable as antigenic sites. The sequence chosen is
clear of any signal sequences and only has sequence similarity to Saporin another
type-1 RIP that is only found in Saponaria officinalis plants.
The peptide that was synthesised (NH2-GCDGVNKKVRVVKDEAR-OH) also
contained the least amount of hydrophobic amino acids.
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The HPLC results received from Bio-Synthesis, showed a clear peak at 14.83 min
at the following conditions: Column C18, 120A, 5 jl, Column size 4.6 X 150 mm,
Solvent A H2010.05% TFA, Solvent B Acetonitrile/0.05% TFA, Flow rate
0.5 mLlMin and %Gradient 10-60% B.
The Laser Desorption Mass Spectrometry results showed that the purified peptide
was more than 70% pure and has a Mass Spectrum of 1875.6 and a Molecular
Weight of 1872.18 (Bio-Synthesis).
The ELISA results indicated that both rabbits had a titer of 1:25600 towards the
peptide. Bio-Synthesis described these results as excellent.
5.3.2. Western blot analyses
At a dilution of 1:500 of the primary antibody an array of bands was detected with
a main band at 30 kDa, which is the expected size of Dianthin 30 in crude protein
extracts of different cultivars of Dianthus caryophyllus. The pre-bleed also gave
bands at various sizes including at 30 kDa, but this could all be attributed to
protein-protein interactions between the proteins on the membrane and the
antibodies (See Figure 5.2.). The main reason for this interaction probably is the
relative high concentration of the primary antibody used.
A dilution had to be determined where the pre-bleed detected no bands. The
dilution series was taken to the extreme for the pre-bleed and the 8-week bleed,
both was diluted from 1:5000 to 1:106. With the increase in dilution all the other
background bands disappeared. Both sera still detected a band at 30 kDa (See
Figure 5.3.).
Both rabbit samples were tested at a dilution of 1:105 of the primary antibody. Both
samples detected a protein at 30 kDa in the pre-bleed as well as in the 8-week
bleed (See Figure 5.4.).
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30kDa
30kDa
30kD
Figure 5.2. Chemiluminescent Western blots of different Dianthus caryophyllus
cultivars. The primary antibody used in these blots was rabbit serum at different
stages of the inoculation (Pre-bleed, 8-week and lO-week) and at a concentration
of 1:500. a) Lane 1 Dianthus caryophyllus cv Fenbow Nutmeg (FN), lane 2
Dianthus caryophyllus cv Early Mother's Day (EM), lane 3 Dianthus barbatus
(Barb) lane 4 Dianthus caryophyllus cv Giant (G), lane 5 Tobacco and lane 6
Rainbow Marker. b and c) Lane 1G, lane 2 Barb, lane 3 FN, lane 4 EM, lane 5 and
6 tobacco and lane 7 G.
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30kDa
Figure 5.3. Chemiluminescent Western blots with Pre-Bleed and lO-week bleed
sera as primary antibody. All lanes were loaded with Dianthus caryophyllus cv
Fenbow Nutmeg and after blot membranes were cut and treated separately. Lanes
1-8 were treated with the pre-bleed at concentrations 1:100 000 (lane 1 and 2),
1:200 000 (lane 3 and 4), 1:600 000 (lane 5 and 6), 1:1000 000 (lane 7 and 8).
Lanes 9 - 16 were treated with the lO-week bleed at concentrations 1:100 000
(lane 9 and 10), 1:200 000 (lane 11 and 12), 1:600000 (lane 13 and 14), 1:1000
000 (lane 15 and 16).
Figure 5.4. Chemiluminescent Western blot to compare the different sera of the
two rabbits. Lanes 1, 4, 7 and 10 were loaded with Dianthus caryophyllus cv
Fenbow Nutmeg and the remaining lanes with tobacco negative controls. Lanes 1-
6 are the results with the antisera of Rabbit 2850 and Lanes 7-12 of Rabbit 2851.
Lanes 1, 2, 3 and 7, 8, 9 are the results of the different rabbits with the pre-bleed
sera and Lanes 4,5,6 and 10, 11, 12 from the lO-week sera.
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A 30 kDa protein band was detected throughout all the experiments III only
Dianthus caryophyllus and not in tobacco or in other Dianthus species.
Unfortunately the band was also detected with the pre-bleed sera from both rabbits
used in the inoculations. From the results obtained it seems unlikely that the band
detected was not Dianthin 30. However, the question then still remains why the
band was also detected with the pre-bleed sera. There is a slight possibility that the
rabbits have inherent antibodies to one of the epitopes presented by the peptide that
would generate cross reactivity. Itmight also be a simple case of sera being labeled
wrong. Whatever the case might be, the fact now remains that it is impossible to
tell if the sera were labeled incorrectly and no conclusive results can be obtained
using these antibodies.
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Chapter 6: Expression of Dianthin 30 in Tobacco
6.1. Introduction
Genetically transformed plants have revolutionized plant molecular biology in
fundamental and applied science [137]. The transformation of important crop plants has
not been perfected and with the use of model plants, constructs can be tested for their
effects and efficiency. Model plants like Nicotiana tabacum are ideal, as they are easy to
transform with foreign DNA and regenerate to form mature seed producing fertile plants.
The most commonly used method to transform tobacco is by means of the pathogenic
bacterium Agrobacterium tumefaciens, other methods like particle bombardment can also
be used but require more skill and resources.
Agrobacterium tumefaciens is a soil-borne, plant pathogen that induces gall formation on
infected plants [138]. A. tumefaciens contains a large tumor inducing (Ti) plasmid that is
responsible for the delivery of the transfer-DNA (T-DNA) that contains the phytohormone
genes that cause disease symptoms [139]. The T-DNA is randomly incorporated into the
nucleic DNA of the plant cell.
The mechanism of gene transfer of this naturally occurring plant pathogen has been
utilized extensively by scientists to transform plants in its host range with genes of
scientific and economic importance. To achieve this, the Ti plasmid had to be modified to
prevent disease symptoms from occurring on the transformed plants [138]. The T-DNA
that carried these genes was largely removed and new gene constructs with all the control
and selection elements were introduced by recombination. The alternative to the
recombination approach came with the observation that the left and right borders are the
only cis acting elements necessary for the transfer of the T-DNA, and that all the other
elements can function in trans [140]. This led to the development of the intermediate
vector or the binary vector system. In the binary vector system, the T-DNA region of the
Ti-plasmid is removed to create a non-oncogenic A. tumefaciens strain. The binary vector
can carry the T-DNA and contains all the elements to be replicated in A. tumefaciens and
E. coli, as well as all the elements for selection in the bacterial and plant stages of the
experiments [141]. The binary vector can then be introduced into the A. tumefaciens by
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electroporation, transformation or triparental mating that requires a third plasmid (helper).
For the expression in plants in this study, the binary expression system, pART, developed
by Gleave in 1992 was used [142].
The pART system consists of a primary cloning vector pART7 and the binary vector
pART27. Genes of interest are cloned into pART7 which contains a small MCS flanked
by a CaMV35S promoter and the oes terminator. The whole construct can be liberated
with the Not! restriction enzyme. The pART27 binary vector contains all the elements for
replication in A. tumefaciens and E. coli with resistance to spectinomycin, streptomycin
and kanamycin. Flanked by the RB and LB, the vector also has the lacZ gene and anptIl
gene driven by the pnos promoter [142]. The construct can then be cut from pART7 with
NotI and cloned into pART27 at the internal NotI site that will disrupt the lacZ gene.
The expression of RIPs in tobacco has been largely unsuccessful with very few
laboratories reporting positive results. The main problems occurring are very low
transformation ratios, stunted growth and the production of sterile plants. Most of these
reports come from studies into PAP expression and although very little homology exists
with Dianthin 30, the possibility exists that similar results might be obtained [68, 89, 98].
The aim of expressing Dianthin 30 in tobacco was to engineer broad-spectrum virus
resistance into tobacco as a model for grapevine. Previous studies by Hong et al. indicated
that this approach had the potential to produce virus resistant plants [97, 98]. Our study
differed from that of Hong et al. in that we were expressing Dianthin 30 constitutively and
they used the virion-sense promoter of the African cassava mosaic virus (ACMV) that was
transactivated by the gene product of the viral gene AC2 [97,98]. Hong et al. maintained
that the advantage of using an inducible promoter was that the expression of the RIP gene
was restricted to the infected cells. They were however unable to show any Dianthin 30
specific transcript in resistant plants [98]. One of the disadvantages of having an inducible
promoter is that any resistance gained from the introduced construct will be limited to the
infection of one virus or virus family. This is one of the limitations of pathogen-derived
resistance [137]. With the shortcomings of PDR and similar approaches and in our
attempts to engineer broad-spectrum virus resistance, it was decided that the constitutive
expression of Dian thin 30 would be attempted in this study.
Stellenbosch University http://scholar.sun.ac.za
60
6.2. Experimental procedures
6.2.1. Cloning of Dianthin 30 into pCambia3301
Before using the pART system, an attempted was made to clone into a 11307 bp
binary vector with the bar gene for resistance in planta developed by Cambia
pCambia330. The plasmid was isolated and confirmed with RE digests. Dianthin
30 was amplified from pGEM Dian (Chapter 3) with primers that amplified the
whole Dianthin 30 gene and incorporated the restriction sites Neol and Pmli on the
5' and 3' ends respectively. The GUS gene was liberated from pCambia3301 using
Neol and Pmll, and the amplified Dianthin 30 was also digested with the same
enzymes, for ligation. The vector to insert ratios used for the ligation ranged from
1:225-1:0.5 with two different ligation systems, T4 ligase from New England
Biolabs (NEB) and All Phor One T4 ligase (Pharmacia). Both enzymes were used
as suggested by the manufacturers and transformed into competent DH5a cells.
6.2.2. Cloning of Dianthin 30 into pART27
Cloning into pART27 is made easier with the help of the cloning vector pART7.
To facilitate the cloning into pART7 the restriction sites Kpnl and Xbal had to be
added to the 5' and 3' ends of Dianthin 30. Dianthin 30 was subcloned into
pBluescriptSK, a phagemid from Stratagene, to obtain these restriction sites. This
was done by amplifying Dianthin 30 with the DNA polymerase pfx from
GibcoBRL and ligated into pBluescriptSK that was digested with the EeoRV.
Positive (white) colonies from the blue/white selection were selected and the
pDNA isolated for RE digests to confirm insert and check orientation. A positive
plasmid, designated pSK-Dian and pART7 was then digested with Kpnl and Xbal
and purified after separation by gel electrophoresis (1.4% Agarose-TAE). The
purified digestion products were then ligated with T4-ligase (NEB). Colonies from
the transformation were screened with PCR (Dianthin 30 specific primers) and
pDNA from positive colonies were isolated and confirmed with a BamHI digest.
pART7-Dian was then digested with Notl to excise the construct containing the
CaMV35S promoter, Dianthin 30 and the oes terminator. The construct and the
backbone DNA were the separated on a 1.4% Agarose-TAE gel. The construct was
Stellenbosch University http://scholar.sun.ac.za
61
carefully purified from the gel and used for ligation into pART27. pART27-Dian
binary vector was isolated from colonies generated from the transformation and
screened with PCR and confirmed with RE digests.
6.2.3. Transformation of A. tumefaciens
Two methods were used to introduce pART27-Dian into A. tumefaciens;
triparental mating and direct transformation [141, 143].
The triparental mating procedure was used for the transformation of the A.
tumefaciens strain LBA4404. pART27-Dian was introduced into LBA4404 with
the help of the helper plasmid pRK2013 [141]. The A. tumefaciens colonies
produced from the triparental mating were screened with PCR and the positive
colonies were used in the transformation of tobacco leaf discs.
The least time consummg and simpler method of direct transformation was
described by Tzfira et al. and this method was also used for the transformation of
A. tumefaciens with pART27-Dian [143]. In this method the A. tumefaciens strain
GV3101 was made competent with a 20 mM CaCh solution and the plasmid DNA
(pART27-Dian) transformed into the cells with freeze/thaw steps. The colonies
obtained from this transformation were tested with peR.
6.2.4. Transformation of Nicotiana tabacum
Several batches of tobacco leaf discs were transformed with the two strains of A.
tumefaciens. With the LBA4404 strain about 200 Nicotiana tabacum cv Xanthi
leaf discs were transformed and with the GVA31 01 about Nicotiana tabacum cv
Petit Havana (SRI) 600 discs were transformed. One set of 100 Nicotiana tabacum
cv. Petit Havana (SRI) leaf discs from in vitro material were also transformed by
ARC-InfruitechlNietvoorbij with the GV3101 strain.
All transformations were performed as set out in Section 4 of Methods in plant
molecular Biology written by Svab et al. [141]. Sterile in vitro plant material was
used for the transformation of Nicotiana tabacum cv Xanthi. For the
transformation of Nicotiana tabacum cv Petit Havana (SRI) leaves were surface
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sterilized by submerging leaves in 70% EtOH for one minute and 20 minutes in
0.5% sodium hypochlorite and thoroughly rinsed with autoclaved water.
A. tumefaciens strains containing pART27-Dian were grown to a density of
OD6oo=1 at 28°C in LB with antibiotic selection (Rif 100 ug/ml., Sp 100 ug/ml.,
St 50 ug/ml.). The cells were harvested and suspended in medium without
antibiotics. Leaf discs were incubated at room temperature in the cell suspension
for 20 minutes. The leaf discs were then blotted dry and placed on co-cultivation
MS medium (See Table 6.1 for all medium compositions). After 4 days of co-
cultivation A. tumefaciens growth was visible and leaves were dipped in water
containing 400 ug/ml, cefotaxime and placed on regeneration MS medium. Leaf
discs were replanted every 2 weeks and when shoots formed, leaves were plated
onto root MS medium.
Table 6.1.
Media used in the transformation of Nicotiana tabacum leaves
Co-cultivation MS medium MS Salts and Vitamins
8 g/L Phyto Agar
1.0mglLBAP
0.1 mglLNAA
pH5.8KOH
30 gIL Sucrose
Regeneration MS medium MS Salts and Vitamins
8 gIL Phyto Agar
1.OmglLBAP
0.1 mglLNAA
pH5.8KOH
30 giL Sucrose
50 ug/ml. Km and 400 ug/ml, Cx
Rooting MS medium MS Salts and Vitamins
8 g/L Phyto Agar
0.1 mglLBAP
1.OmglLNAA
pH5.8KOH
30 giL Sucrose
50 ng/ml. Km and 400 ug/ml, Cx
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6.2.5. Molecular analysis of putative transformed plants
Genomic DNA extractions were performed according to the CTAB method as
described by C van Straten [4]. Very little material was available and DNA pellets
were dissolved in minimum volumes of sterile water containing 20 ug/ml. RNAase
A (Roche).
PCR was performed on plants that rooted on antibiotic containing media with
Dianthin 30 specific primers and CaMV35S primers. The PCR product was then
separated on a 1.4% Agarose-TAB Gel.
For the Southern blot analysis the maximum volume of isolated gDNA was RE
digested with HindIII overnight at 37°C. The digested gDNA was then separated
on a 0.8% Agarose- TAB gel for 10 hours. The DNA was then transferred to a
positively charged nylon membrane, Hybond + (Amersham) using downward
capillary transfer in an alkaline buffer as described in the FMC Guide to DNA
transfer and analysis [144].
The DNA was detected using DIG Filter Hybridization (Roche). The 730 bp probe
was PCR labeled with Dianthin 30 specific primers as described in the DIG
applications Manual [145]. All techniques followed for the detections of DNA on
the membrane were done as described in the DIG-Manual [145].
6.3. Results and discussion
6.3.1. Cloning of Dianthin 30 into pCambia3301
After initial experiments that yielded no transformed colonies, a range of ratios and
two ligation systems were used. None of these yielded any colonies except for the
control experiments that indicated that the transformation of DH5a cells with
pCambia3301 was possible and that the ligation of pCambia3301 was possible
after it was digested. All attempts to clone Dianthin 30 into pCambia3301 failed,
probably because of the large size difference between the vector and the insert.
Stellenbosch University http://scholar.sun.ac.za
6.3.2. Cloning of Dianthin 30 into pART27
The pART system was used for the transformations as it had the advantage of a
cloning vector that aided transformation into the plant expression vector. Dianthin
30 was first cloned into pBluescriptSK to obtain the restriction sites KpnI and XbaI
that could be used to clone into the cloning vector pART7 (see Figure 6.1a). This
was done by amplifying Dianthin 30 with a DNA polymerase, pfx that did not
leave an A overhang on the PCR product and cloned into EcoRV (blunt cutter)
digested pBluescriptSK. The MCS of pBluescriptSK is in a lacZ gene and thus
gives the added advantage of blue/white selection. The positive (white) colonies
were tested for orientation with BamHI digests. Dianthin 30 in the correct
orientation (to be used for cloning into pART7) would yield an 850 bp fragment if
digested with BamHI (see Figure 6.1.a) and from Figure 6.1.b it is clear that of all
the plasmids tested, only one did not give the correct band pattern.
a b
pSK-Dian
3840 bp
Dianthin 30
BamH 1(1602)
Xba I (1614)
Figure 6.1. a) Restriction map of pSK-Dian indicating RE sites and orientation
needed for Dianthin 30 to gain KpnI and XbaI on the 5' and 3' ends. b) RE digest
of different pSK-Dian isolates from white colonies digested with BamHI (Note one
escape).
Both pSK-Dian and pART7 were digested with KpnI and XbaI and the band with
Dianthin 30 was purified from an agarose gel. The transformation yielded many
64
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colonies, as the digested pART7 plasmid was not SAP treated thus allowing the
plasmid that was only cut with one enzyme to re-ligate without the insert.
Treatment with Shrimp Alkaline Phosphatase (SAP) will catalyse the
dephosphorylation the 5' phosphates of the DNA strand and thus prevent any re-
circulization of liniarized plasmid. All the colonies were screened with peR and it
was found that about 20% did contain the insert. The positive colonies were
confirmed with RE digests and one was used for cloning into pART27. See Figure
pART7-Dian for digest ofpART7-Dian.
lkb
Figure 6.2. pART7-Dian digested with BamHI to confirm insert ofDianthin 30.
pART7-Dian and pART27 were digested with NotI and the fragment containing
Dianthin 30 was ligated into the digested pART27 (See Figure 6.3). The
transformation was confirmed with peR (See Figure 6.4.). Only 50% of tested
colonies contained the insert and this could be attributed to the fact that the vector
was not SAP treated. The colonies tested positive by peR were also verified to be
positive with RE digests (See Figure 6.5.)
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RB
An1>R
pART 7 -Dian
5994 bp
DIANTHlN pART 27 - Dian
14797 bp
-,
LB
Figure 6.3. Restriction maps ofpART7-Dian and pART27-Dian
BmnHI(1679)
Not 1(3133)
1 kb
1 kb
Figure 6.4. peR screening of pART27-Dian colonies. From the photo it is clear
that not all the colonies did contain the construct.
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lkb
Figure 6.5. pART27-Dian digested with BamHI.
6.3.3. Transformation of A. tumefaciens
The transformation of A. tumefaciens was successful with both methods. The
triparental mating yielded transformed LBA4404 cells (see Figure 6.6.) and the
direct transformation, transformed GV31 01 cells. Both transformations were
confirmed with stringent antibiotic selection and peR (see Figure 6.7.).
Figure 6.6. LB plate with transformed A. tumefaciens cells after tri-parental
matings.
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lkb
Figure 6.7. peR screen A. tumefaciens strains for pART27-Dian with primers that
would amplify the whole sequence. Lane I 1 kb+ Marker (GibcoBRL), lane 2 and
5 negative controls, 3 LBA4404, lane 4 GV3101.
6.3.4. Transformation of Nicotiana tabacum
Transformation ofpART27-Dian was performed on Nicotiana tabacum cv Xanthi
and Petit Havana (SRI) leaf discs. From the approximately 200 Xanthi leaf discs
(in vitro material) transformed with LBA4404, 56 plants were generated. With the
Petit Havana (SRI) leaves, no plants were generated after almost 600 leaf discs
that were transformed with LBA4404 and GV31 01.The stringent sterilization
might have been too robust for the young leaves, but attempts with less stringent
sterilization yielded too much fungal contamination. Petit Havana (SRI) leaf discs
(in vitro material) transformed with GV31 01 yielded 20 plants from 100 discs.
6.3.5. Molecular analysis of putative transformed plants
The peR screening of the putative positive plants yielded positive results with the
Dianthin 30 specific primers and the eaMV35S primers (See Figure 6.8.). The
peR also included the necessary negative controls.
A 730 bp probe was peR labeled using Dianthin 30 specific primers (see Figure
6.9.) From the Figure it can be deduced that the labeling was successful and very
efficient. The gDNA isolated was digested with HindIII overnight and separated
(see Figure 6.10). The smears indicated that the concentration of gDNA isolated
might be too low to detect any bands.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Figure 6.8.Results of peR screen of putative transformed tobacco plants. Lanes 2-
10 were tested with the Dianthin internal primers and lanes 11-19 with the
eaMV35S primers. Lanes 8 and 17 were DNA negatives and 9 and 18 were water
negatives. The samples were loaded in lanes 2 -7 and same samples in 10-16 but
with different primers.
1kb
Figure 6.9. peR products of Dianthin 30 specific primers for the production of a
DNA probe. The size difference between labeled and unlabeled peR product is
clearly visible.
The Southern blot was only able to detect a band in the positive control. The main
reason why all plants tested negative, apart for the possibility that the plants might
not be transformed was that relative concentration of gDNA used in the blots was
too low (See Figure 6.10. and 6.11.).
From all the plants tested with the Southern blots, no transformed plants were
detected. There is a possibility that the DNA concentration on the blots was too
low but it is more likely that the plants were not transgenic even though the plants
were tested positive with peR. An explanation might be that the plant cells that
were transformed were not able to grow into embryos. Another reason that
supports the conclusion that no transformed plants were generated, is the
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observation that some plants that rooted on antibiotic containing media died when
replanted. This was a common occurrence and could only be explained as residual
Agrobacterium growth that helps the plant to cope with the antibiotics in the
media. The positive peR results could also be explained in view of this conclusion.
1f- 2 - 13 ------I
Figure 6.10. HindIII Digest of gDNA of putatively transformed tobacco plants.
Lane 1 is the positive control and lanes 2-13 are the putative transformed plants.
Figure 6.11. Southern blot of the above shown agarose gel indicating only the
positive control with less than 0.4 ng DNA.
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Chapter 7: Conclusion
RIPs hold great promise to be one of the major role players in broad-spectrum VIruS
resistance in transgenic agricultural crops. This initial study highlights some of the hurdles
that first need to be cleared before such crops can be produced.
In an attempt to express rDianthin 30, a bacterial expression system was initially used. The
bacterial expression with the pET14b vector was successful but at such a low concentration
that it was not useful for the main aim of the project, which was to produce Dianthin 30
antibodies. It appears that the toxicity of the protein might be too great for the bacteria to deal
with sufficiently. Other researchers also observed similar low expression levels.
To rDianthin 30 at higher concentrations, expression in insect tissue culture was attempted. It
was hoped that the eukaryotic system would be better equipped to deal with the toxicity of
the protein, but this system also yielded recombinant proteins at such low levels that they
were insufficient for use as an antigen. To my knowledge this is the first attempt at
expressing Dianthin 30 in insect cells.
Despite the above failures in expressing sufficient protein for antibody production to detect
Dianthin 30 at least in carnations, a peptide was designed that would represent Dianthin 30
and could be used as antigen for the production of Dianthin 30 specific antibodies. The
synthesis and rabbit immunisation were sub-contracted to Bio-Synthesis Incorporated. The
antibodies received were tested and did detect a protein at 30 kDa (size of Dianthin 30) only
in Dianthus caryophyllus cultivars and not in tobacco or even Dianthus barbatus.
Unfortunately, the pre-bleed serum also detected the same protein. The only reasonable
explanations for these results would be that the rabbits have inherent antibodies to one of the
epitopes presented by the peptide that would generate cross reactivity or that the "pre-bleed"
received was one of the later bleeds and was labeled incorrectly.
The plant transformations yielded no transformed plants. Repeated efforts to produce these
plants were unsuccessful. Other studies also indicated that the expression of a RIP in
transgenic plants could have an adverse effect on the growth of the host plant. The only other
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study that used Dianthin 30 was unable to show Dianthin 30 specific transcripts in the
transgenic plants.
In an attempt to reach the goal of producing transgenic crops that would have broad-spectrum
virus resistance this study has shown that the choice of gene is extremely important. The
toxicity of the exogenous protein to the plant physiology needs to be taken into account. A
more toxic RIP does not necessarily mean more resistance would be gained from it as it
might not result in transgenic plants. An alternative approach would be to express the RIP
under the control of an inducible promoter that might lessen the impact of the RIP on the
plant's system.
It is possible to use RIPs in transgenic plants to gain resistance to a range of pathogens. To
achieve this might be more difficult than other methods but the possible rewards do warrant
the risk and difficulty in this approach.
It might not have been the answer you were hoping for but here it is .
" 'Forty-two' said Deep Thought, with infinite majesty and calm."
The Hitch Hiker's Guide to the Galaxy, Douglas Adams
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